methylprednisolone and MS (Multiple Sclerosis)

methylprednisolone has been researched along with MS (Multiple Sclerosis) in 539 studies

Research

Studies (539)

Timeframe	Studies, this research(%)	All Research%
pre-1990	81 (15.03)	18.7374
1990's	154 (28.57)	18.2507
2000's	155 (28.76)	29.6817
2010's	119 (22.08)	24.3611
2020's	30 (5.57)	2.80

Authors

Authors	Studies
Evangelopoulos, DS; Evangelopoulos, ME; Kassi, E; Moutsatsou, P; Nasiri-Ansari, N; Papadopoulou, A	1
Chevreul, K; Coustans, M; Edan, G; Laplaud, DA; Le Page, E; Lebrun, C; Michel, M; Veillard, D; Wardi, R; Wiertlewski, S; Zagnoli, F	1
Auer, M; Berek, K; Berger, T; Bsteh, G; Deisenhammer, F; Di Pauli, F; Hegen, H; Krajnc, N; Leutmezer, F; Riedl, K; Zinganell, A	1
Begum, Z; Gurusamy, K; Raghunath, G; Sivanesan, S; Subramanian, V; Vijayaraghavan, R	1
Battaglia, MA; Bergamaschi, R; Bovis, F; Bragadin, MM; Capobianco, M; Carmisciano, L; Cavalla, P; Cocco, E; Comi, G; Confalonieri, P; Cordioli, C; De Rossi, N; Efendi, H; Fragoso, YD; Furlan, R; Immovilli, P; Inglese, M; Karabudak, R; Landi, D; Moiola, L; Patti, F; Perini, P; Pesci, I; Petracca, M; Ponzano, M; Radaelli, M; Salvetti, M; Scandellari, C; Schiavetti, I; Sen, S; Siva, A; Sormani, MP; Tedeschi, G; Trojano, M	1
Azimi, AR; Farhadi Shabestari, HR; Ghadiri, F; Jamali, R; Namaei, P; Vahabizad, F	1
Ashkenas, J; Borsellino, L; Leckey, R; Rawlings, AM; Suri, A	1
Castillo Rocha, PA; Hon, KLE; López-Benítez, J; Mohanty, M; Torres, AR	1
Batlle-Nadal, J; Blanco, Y; Brieva-Ruiz, L; Cano-Orgaz, A; Capellades, J; Carmona, O; Gea, M; Hervás-García, JV; Martín-Aguilar, L; Massuet-Vilamajó, A; Moral, E; Presas-Rodriguez, S; Ramió-Torrentà, L; Ramo-Tello, C; Rovira, À; Tintoré, M	1
Bittner, S; Brand, M; Gross, CC; Klotz, L; Meuth, SG; Pawlitzki, M; Pfeuffer, S; Rolfes, L; Ruck, T; Schulte-Mecklenbeck, A; Steffen, F; Wiendl, H; Wirth, T	1
Amini Harandi, A; Ilkhani, S; Karamiani, F; Mohammadi, F; Pakdaman, H; Sahraian, M; Shirzadeh Barough, S; Siavoshi, F	1
Albrecht, P; Beisse, F; Diem, R; Grotejohann, B; Heinrich, SP; Hug, MJ; Ihorst, G; Küchlin, S; Lagrèze, WA; Ungewiss, J; Wolf, S; Wörner, M	1
Cipollone, V; Curan, M; Fletcher, E; Hoyle, B; Iannotta, C; Shull, C	1
Abu El-Asrar, AM; Al-Obailan, M; Al-Swaina, NF; AlBloushi, AF; Daif, AK; Dheyab, AM	1
Alcaraz-Estrada, SL; García, S; Quiñones-Aguilar, S; Sauri-Suárez, S	1
Berkenblit, G; Hollander, H; Manesh, R; McArthur, JC; Moffett, AT	1
Boricic, I; Dragasevic, S; Dumic, I; Jankovic, K; Milovanovic, T; Stojkovic Lalosevic, M	1
Hasegawa, I; Itoh, Y; Kikukawa, T; Kimura, H; Mino, T; Ohsawa, M; Takeda, A; Uchida-Kobayashi, S	1
Fotopoulos, A; Kiortsis, DN; Kostadima, V; Nikas, D; Sioka, C; Tsoumani, A	1
Cabrera-Maqueda, JM; Carreón-Guarnizo, E; Fuentes-Rumí, L; Hernández-Clares, R; Iniesta-Martinez, F; León-Hernández, A; Meca-Lallana, JE; Morales-Ortiz, A; Valero-López, G; Zamarro-Parra, J	1
Aktoz, G; Boz, C; Caglar, A; Ozbudun, B; Sen, S; Şener, M; Terzi, M; Zengin Karahan, S	1
Alonso, R; Garcea, O; Saidon, P; Segamarchi, C; Silva, B	1
Chao, J; Levasseur, K; Saleem, S; Stec, LA; Tausif, HN	1
Li, G; Li, H; Ma, Z; Wang, M; Wang, XY; Wang, Z; Yi, H; Zheng, G	1
Alcalá Vicente, C; Bastida Paz, G; Ladrón Abia, P; Martínez Delgado, S	1
Baghbanian, SM; Bazi, A; Ghazaeian, M; Hendoiee, N; Saeedi, M	1
Boeckers, TM; Delling, JP; Jesse, S; Ludolph, A; Schön, M; Senel, M	1
Candrian, U; Deandrea, M; Disanto, G; Gobbi, C; Limone, PP; Riccitelli, GC; Sacco, R; Zecca, C	1
Cleanthous, M; Kinnis, E; Kyriakides, T; Lambrianides, S; Leonidou, E; Myrianthopoulou, P	1
Hemingway, C; Lim, M; Luchesa Smith, A; Sudarsan, N	1
Fernández, Ó; Luetic, GG; Menichini, ML	1
Bernitsas, E; Pakneshan, S	1
Boz, C; Emrah Mavis, M; Sarac, Y; Sen, S; Terzi, M; Zengin Karahan, S	1
Busch, M; Krizek, L; Stoppe, M; Then Bergh, F	1
Dokoohaki, S; Farhadi, N; Ghanbari, A; Ghareghani, M; Sadeghi, H; Zibara, K	1
Chen, S; Liu, S; Liu, X; Xiao, Y; Zhuang, W	1
Jeun, SS; Kim, MJ; Kim, WS; Lim, JY; Park, SA; Park, SI; Ryu, CH	1
Bilgiç, A; Bölük, C; Köseoğlu Toksoy, C; Taşdemir, M; Türk Börü, Ü	1
Río, J; Rodríguez-Acevedo, B	1
Chetty, S; Kobayter, L	1
Bianco, A; Biolato, M; De Fino, C; Grieco, A; Losavio, FA; Lucchini, M; Marrone, G; Mirabella, M; Nociti, V	1
Adamec, I; Habek, M; Pavičić, T; Pavlović, I; Ruška, B	1
Azizi, M; Borhani-Haghighi, M; Kashani, IR; Madadi, S; Nekoonam, S; Noorzehi, G; Pasbakhsh, P; Tahmasebi, F	1
Estiasari, R; Imran, D; Kusumadewi, W; Maharani, K; Marwadhani, SS; Pakasi, TA; Pangeran, D; Rusmana, AI; Witjaksono, F	1
Campbell, A; Ogundipe, OA	1
Arndt, N; Cipriani, VP; Conte, WL; Dellaria, A; Javed, A	1
Di Stefano, V; Graziosi, A; Mohn, AA; Rotondo, E	1
Arvaniti, P; Dalekos, GN; Gyftaki, S; Hadjigeorgiou, G; Koukoulis, GK; Rigopoulou, EI; Tsimourtou, V	1
Hauser, SL; Julian, L; Kappos, L; Köndgen, H; Li, C; Mayer, L; Napieralski, J; Racke, MK; Rammohan, K; Traboulsee, A; Wolinsky, JS; Zheng, H	1
Rae-Grant, AD	1
Bašić Kes, V; Jadrijević Tomas, A; Jurašić, MJ; Lisak, M; Zavoreo, I	1
Andrade, RJ; Contreras, F; Crespo, J; García-Cortés, M; González-Jiménez, A; Hernández, N; Lucena, MI; Medina-Cáliz, I; Ortega-Alonso, A; Pinazo-Bandera, J; Robles-Díaz, M; Sanabria-Cabrera, J; Sanjuan-Jiménez, R; Zoubek, ME	1
Chassain, C; Clavelou, P; Dallel, R; Mathais, S; Moisset, X; Perrey, A; Poncet-Megemont, L	1
Aboul-Enein, F; Bayas, A; Blaschek, A; Debelic, D; Hellwig, K; Karenfort, M; Kornek, B; Kristoferitsch, W; Meyer, A; Milos, RI; Penzien, J; Pitarokoili, K; Prayer, D; Rostasy, K; Seidl, R; Steiner, I; Storm van's Gravesande, K; Vass, K	1
D'Agnolo, HM; Drenth, JP	1
Findling, O; Humpert, S; Kamm, CP; Lienert, C; Mathis, J; Mattle, HP; Mugglin, A; Schawalder, G; Sturzenegger, M	1
Csepany, T; Csiba, L; Kardos, L; Kovacs, RK; Mezei, Z; Olah, L	1
Fletcher, M; Hageman, J; Joseph-Griffin, M; Rabiah, PK	1
Balcer, LJ; Bermel, RA	1
Malhotra, A; Needham, M; Reyneke, E	1
Dai, YQ; Hu, XQ; Lu, ZQ; Qiu, W; Ruan, HF; Shu, YQ; Wang, YG; Wu, AM; Xiao, L; Yang, Y	1
Bendszus, M; Diem, R; Lanz, T; Platten, M	1
Kvistad, SA; Myhr, KM; Torkildsen, Ø; Vedeler, CA; Wergeland, S	1
Idiman, E; Ozakbas, S; Piri Cinar, B	1
Brieva, L; Cano, A; Carmona, O; Costa, J; Giner, P; Grau-López, L; Martínez-Cáceres, E; Massuet, A; Montalbán, X; Nos, C; Ramió i Torrenta, L; Ramo-Tello, C; Rovira, A; Saiz, A; Tintoré, M; Torres, F	1
Bagherzadeh, S; Bazrafshani, MR; Daneshvar, H; Ebrahimi, HA; Gadari, F; Hajghani, H; Iranmanesh, F; Jafarzadeh, A; Khosravimashizi, A; Mohammadi, MM; Nemati, M; Sabahi, A	1
Amato, MP; Comi, G; De Giglio, L; De Luca, G; Ghezzi, A; Hakiki, B; Lugaresi, A; Mancardi, GL; Marrosu, MG; Martinelli, V; Moiola, L; Paolicelli, D; Patti, F; Portaccio, E; Pozzilli, C; Solaro, C; Sturchio, A; Tola, MR; Totaro, R; Trojano, M	1
Ataoglu, S; Baltaci, D; Besir, FH; Dikici, S; Kocaman, G; Ozsahin, M	1
Badgett, D; Bergsland, N; Bodziak, ML; Browne, RW; Hagemeier, J; Havrdova, E; Horakova, D; Krasensky, J; Ramanathan, M; Ramasamy, DP; Seidl, Z; Tamaño-Blanco, M; Tyblova, M; Vaneckova, M; Weinstock-Guttman, B; Zivadinov, R	1
Bi, J; Liu, Z; Wang, C; Wang, P; Xie, Z; You, W; Zhu, Z	1
Dhurandhar, A; Fountain, EM	1
Anderson, B; Cree, BA; De Sèze, J; Duda, P; Fox, RJ; Gold, R; Hartung, HP; Jeffery, D; Kappos, L; Kaufman, M; Montalbán, X; Natarajan, A; Ticho, B; Weinstock-Guttman, B	1
Chataway, J	1
Brieva, L; Cano, A; Carmona, O; Grau-López, L; Hervás, JV; Martínez-Cáceres, EM; Ramió-Torrenta, L; Ramo-Tello, C; Rovira, A; Saiz, A; Teniente-Serra, A; Tintoré, M	1
Börnsen, L; Ratzer, R; Romme Christensen, J; Romme Nielsen, B; Sellebjerg, F; Sørensen, PS	1
Bi, J; Wang, C; Wang, P; Xie, K	1
Daneshvar, H; Ebrahimi, HA; Hajghani, H; Jafarzadeh, A; Jamali, M; Khosravimashizi, A; Mahdavi, R; Mohammadi, MM; Najafipour, H; Nemati, M; Sheikhi, A	1
Borazanci, A; Chang, GQ; Fu, Y; Li, YJ; Qi, Y; Shen, Y; Shi, FD; Su, L; Sun, N; Yan, Y; Yang, C; Zhang, F	1
Ohashi, T	1
Baker, TE; Cooper, SD; Felkins, K; Hale, TW	1
Marignier, R; Vukusic, S	1
Changhong, D; Chunhong, C; Fang, F; Haitao, R; Jiuwei, L; Junlan, L; Liying, C; Weihua, Z; Xiaotun, R; Xinying, Y; Yun, W	1
Cipriano, MA; Lopes, S; Oliveira, AT; Sofia, C	1
Accoto, S; De Blasi, V; De Donno, A; De Masi, R; Idolo, A; Orlando, S; Pasca, S; Scarpello, R; Spagnolo, L	1
Cocuzza, S; Di Mauro, P; Falsaperla, R; Ledda, C; Lubrano, R; Matin, N; Pavone, P; Serra, A; Tabatabaie, O; Vitaliti, G	1
Fitzgibbons, TP; Kundu, A	1
García-Rodríguez, JR; Hervás-García, M; López-Méndez, P; Muñoz, A; Ruano, A	1
Brieva, L; Cano, A; Carmona, O; Grau-López, L; Hervás, JV; Ramió-Torrenta, L; Ramo-Tello, C; Rovira, A; Saiz, A; Tintoré, M	1
Fujihara, K; Fukaura, H; Fukazawa, T; Kaida, K; Kanda, T; Kawachi, I; Kira, J; Matsui, M; Matsushita, T; Miyamoto, K; Mizusawa, H; Murai, H; Nagaishi, A; Nakatsuji, Y; Niino, M; Nomura, K; Ochi, H; Ogino, M; Ohashi, T; Tanaka, M; Togo, K; Tomioka, R; Yamasaki, R; Yokota, T; Yokoyama, K	1
Ben Achour, N; Ben Waddey, O; Ben Youssef-Turki, I; Benrhouma, H; Klaa, H; Kraoua, I; Rouissi, A	1
Acebal-Montero, A; Ávalos-Franco, N; Fernández-Vigo, JI; García-Sánchez, J; Porta-Etessam, J; Santos-Bueso, E	1
Miranda, MJ; Olofsson, IA; Skov, L	1
Andreadou, E; Evangelopoulos, DS; Evangelopoulos, ME; Kilidireas, C; Koutoulidis, V	1
Celik, HT; Gencler, OS; Gunduz, S	1
Hillen, M; Jain, S; Sheikh, Z	1
Daniilidis, M; Giantzi, V; Grigoriadis, N; Karapanayiotides, T; Lagoudaki, R; Lourbopoulos, A; Milonas, I; Poulatsidou, KN; Taskos, N	1
Kanaya, Y; Kitajima, I; Kuriyama, M; Niimi, H; Shimoe, Y; Takamatsu, K	1
Arlazoroff, A; Dvir, Z; Gandelman-Marton, R	1
Banwell, B; Narula, S	1
Damal, K; Gold, LS; Hansen, RN; Schepman, PB; Suh, K	1
Biedroń, A; Wesołowska, E; Witek, I	1
Amini, M; Atyabi, F; Dinarvand, R; Gandomi, N; Ghahremani, MH; Sharifzadeh, M; Varshochian, R	1
Diem, R; Heesen, C; Hein, K; Papanagiotou, P; Pul, R; Scholz, K; Sühs, KW	1
Dokoohaki, S; Farhadi, N; Ghanbari, A; Ghareghani, M; Hosseini, SM; Mohammadi, R; Sadeghi, H	1
Carnero Contentti, E; Di Pace, JL; Diego, A; Hryb, JP; Perassolo, M	1
Aissaoui-Hoffmann, N; Keita, BA; Mallaret, M; Roche, M; Yahiaoui, N	1
Maria, BL; Skinner, HJ; Williams, BJ	1
Volpe, NJ	1
Beck, RW; Gal, RL	1
Braitch, M; Constantinescu, CS; Fahey, AJ; Harikrishnan, S; Nichols, C; Robins, RA; Showe, L	1
Abe, K; Irisawa, A; Kanno, Y; Monoe, K; Ohira, H; Saito, H; Sakamoto, N; Takahashi, A; Takahashi, Y; Yokokawa, J	1
Agaoglu, J; Icen, M; Kale, N; Tanik, O; Yazici, I	1
Attilio Tonali, P; Batocchi, AP; Cammarota, G; Frisullo, G; Iorio, R; Marti, A; Mirabella, M; Nociti, V; Patanella, AK	1
Achiron, A	1
Bendtzen, K; Christensen, O; Hesse, D; Jensen, PE; Ravnborg, M; Sørensen, PS; Tovey, MG	1
Brady, J; Narayan, K; Pachner, AR; Steiner, I	1
Buttmann, M; Toyka, KV	1
Bendtzen, K; Frederiksen, JL; Heltberg, A; Hesse, D; Koch-Henriksen, N; Ravnborg, M; Schreiber, K; Sellebjerg, F; Sorensen, PS; Stenager, E	1
Bolgert, F; Chabas, D; Demeret, S; Fontaine, B; Hasboun, D; Lyon-Caen, O; Weiss, N	1
Dastgir, J; DiMario, FJ	1
Edan, G; Le Page, E	1
Bao, J; Chen, H; Chen, S; Hsu, CY; Michael, D; Xiao, Q; Xu, J	1
Dimitrakopoulos, A; Evangelopoulos, ME; Kararizou, E; Koutsis, G; Nikolaou, C; Rentzos, M; Rombos, A; Sfangos, K; Tsoutsou, A; Zoga, M	1
Benzinger, T; Brown, S; Lenox, J; Mar, S; Noetzel, M	1
Holzknecht, C; Röhl, C	1
Abellán, I; Belenguer, A; Boscá, I; Casanova, B; Coret, F; Fernández, P; Magraner, MJ; Mallada, J; Montalbán, X; Pascual, AM; Sanz, MA; Sempere, AP; Téllez, N	1
Brain, MC; Brown, C; Ruether, B; ter Keurs, H; Valentine, K	1
Yusuf, K	1
Basic, S; Hajnsek, S; Nankovic, S; Pavlisa, G; Petelin Gadze, Z; Sporis, D	1
Ebitani, M; Matsuda, N; Mochizuki, H; Namatame, S; Ugawa, Y	1
Annovazzi, P; Comi, G; Falini, A; Filippi, M; Martinelli Boneschi, F; Martinelli, V; Pulizzi, A; Rocca, MA; Rodegher, M; Scotti, R; Sormani, MP	1
Galiè, E; Jandolo, B	1
Hoogervorst, EL; Kragt, JJ; Polman, CH; Uitdehaag, BM; van Winsen, LM	1
Auh, S; Bagnato, F; Davis, M; Frank, JA; McFarland, HF; Richert, ND; Riva, M	1
Butler, M; Fanning, N; Harrington, H; Mok, TH; Saidha, S	1
Dresler, M; Genzel, L; Kluge, M; Rosenhagen, M; Schüssler, P; Steiger, A; Weber, F	1
Myhr, KM	1
Dubois, B	1
Doi, H; Fujihara, K; Hariya, T; Misu, T; Nakamura, M; Nakazawa, T; Nishida, K; Omodaka, K; Takahashi, T	1
Reitman, NC	1
Trojano, M	1
Gordon-Krajcer, W; Mitosek-Szewczyk, K; Stelmasiak, Z; Walendzik, P	1
Fujihara, K; Itoyama, Y; Misu, T; Sato, S; Takahashi, T; Takano, R	1
Aupy, J; Blanc, F; Bourre, B; Bouyon, M; Collongues, N; de Seze, J; Speeg, C	1
Birnbaum, AD; Goldstein, DA; Li, SY	1
Constantin, G; Murrighile, MR; Sotgiu, S	1
Benyounes, N; Gout, O	1
Glass-Marmor, L; Gour-Lavie, A; Haves-Zburof, D; Mandel, I; Miller, A; Paperna, T	1
Flaig, M; Gerdes, LA; Hohlfeld, R; Kümpfel, T; Wollenberg, A	1
Wender, M	1
Bux, AV; Cristiana, I; Forte, R; Francesco, P; Noci, ND; Querques, G	1
Neubauer, M; Quehenberger, F; Rainer, F; Robier, C; Stettin, M; Strohmeier, L	1
Itoyama, Y; Izumi, R; Nagata, M; Nakashima, I; Nishiyama, S; Omata, K; Suzuki, N	1
Ahbeddou, N; Ait Ben Haddou, E; Benomar, A; Hammi, S; Regragui, W; Slimani, C; Yahyaoui, M	1
Ali, R; Baker, K; Ben-Shlomo, Y; Boggild, M; Coles, A; Cossburn, M; Hirst, C; Ingram, G; Jones, J; Pace, AA; Pickersgill, T; Robertson, NP; Scolding, N; Zajicek, J	1
Aghsaie, A; Darabi, L; Minagar, A; Sahraian, MA; Vasheghani-Farahani, A	1
Barnett, MH; Chohan, G; Davies, L	1
Čapkun, V; Filipović Grčić, P; Lušić, I; Matijaca, M	1
Funatogawa, I; Funatogawa, T	1
Chen, YC; Huang, CF; Lo, CP; Tseng, CY	1
Pohl, M; Wölk, G; Zehlicke, T	1
Annovazzi, P; Bodini, B; Boffa, L; Calabrese, M; Cocco, E; Cordioli, C; De Luca, G; Frisullo, G; Gallo, A; Gasperini, C; Malucchi, S; Paolicelli, D; Pesci, I; Radaelli, M; Ragonese, P; Roccatagliata, L; Rodegher, M; Solaro, C; Tomassini, V; Tortorella, C; Vercellino, M; Zipoli, V	1
Bazelier, MT; Bentzen, J; de Vries, F; Leufkens, HG; Stenager, E; van Staa, TP; Vestergaard, P	1
Ibitoye, RT; Promnitz, DA; Sarkar, P	1
Lindh, J; Malmgren, K; Vrethem, M	1
Baumgartner, A; Gross, CM; Rauer, S; Stich, O	1
Bielekova, B; Martin, J; McFarland, H; Oh, U; Ohayon, J; Richert, N; Vortmeyer, A	1
Asencio Marchante, JJ; Gómez González, B; Rodriguez Fernandez, N; Sánchez Vera, L; Sillero Sánchez, M	1
Carrier, P; Crepin, S; Debette-Gratien, M; Godet, B; Gondran, G; Jacques, J; Labrousse, F; Loustaud-Ratti, V; Magy, L; Pillegand, B; Sautereau, D; Vidal, E	1
Furutera, R; Ikeda, K; Murata, M; Ohsawa, I; Okamoto, T; Yamamura, T	1
Milicic, B; Samardzic, G; Toncev, G; Toncev, S	1
Bauer, G; Benke, T; Berger, T; Niedermüller, U; Spiegel, M; Trinka, E; Unterberger, I	1
Pender, MP; Wolfe, NP	1
O'Connor, P	1
Störh, M	1
Frederiksen, JL; Jensen, CV; Larsson, HB; Sellebjerg, F	1
Dohi, N; Ishikawa, S; Kamijyo, Y; Maruyama, K; Nakamura, T; O-Hara, S	1
Klötzsch, C; Rahimi, A; Schlachetzki, F; Stolz, E	1
Hashimoto, T; Ikeda, S; Kanbayashi, T; Kato, T; Nakano, T; Shimizu, T; Yamamoto, K	1
Baker, G; Boggild, M; Craig, J; Ennis, M; Young, CA	1
Oishi, C; Sakuta, M	1
GOLDSTEIN, NP; McGUCKIN, WF; McKENZIE, BF	1
BOINES, GJ	4
CAPRILES, LF; IDEA, BV; POFFENBARGER, AL; VANBUSKIRK, C	1
CHRISTY, NP; FISHMAN, RA	1
HAERER, AF; TOURTELLOTTE, WW	1
KIBLER, RF	1
HAERER, AF; KUZMA, JW; SIKORSKI, J; SIMPSON, JF; TOURTELLOTTE, WW	1
Ishikawa, H; Iwata, M; Mizutani, T; Shiota, H; Takahashi, T; Tsuda, H	1
Hohlfeld, R; Jarius, S; Voltz, R	1
Blair, J; Sharma, S	1
Araya, S; Matsui, M; Matsushima, K; Onai, N; Saida, T; Wang, HY	1
Amano, N; Joko, T	1
Czlonkowska, A; Czlonkowski, A; Mirowska, D; Weber, F; Wicha, W	1
Plant, GT; van der Worp, HB; van Gijn, J	1
Cagiran, I; Idiman, E; Ormeci, B; Ozakbas, S	1
Johnson, LN; Williams, KE	1
Edan, G	1
Airas, L; Alanen, A; Lehtonen, L	1
Brinar, VV	1
Batinic, D; Brinar, V; Dubravcic, K; Petelin, Z; Petravic, D; Zurak, N	1
Garssen, MP; Hintzen, RQ; Neuteboom, RF	1
Iseki, K; Kanbayashi, T; Matsubayashi, J; Matsui, M; Mezaki, T; Murakami, G; Oka, Y; Shibasaki, H; Shimizu, T	1
Smith, D	1
Beverley, DW; Etheridge, LJ; Ferrie, C; McManus, E	1
Corbett, J	1
Borràs, C; Montalban, X; Nos, C; Río, J; Sastre-Garriga, J; Tintoré, M	1
Bischoff, M	1
Chan, SC; Dmitrovic, J; Metz, LM; Morrow, SA; Stoian, CA	1
Ali Cherif, A; Feuillet, L; Guedj, E; Habib, G; Laksiri, N; Pelletier, J; Philip, E	1
Canyiğit, A; Türkçapar, N; Yücesan, C	1
Angeli, A; Bertolotto, A; Dovio, A; Milano, E; Osella, G; Perazzolo, L; Termine, A; Ventura, M	1
Airla, N; Elovaara, I; Kettunen, E; Knuutila, S; Lehtimäki, T; Luomala, M	1
Balaban, H; Eldem, B; Gedik, S; Kadayifçilar, S; Kansu, T	1
Funakawa, I; Futamura, N; Jinnai, K; Kuga, A	1
Bähr, M; Demmer, I; Diem, R; Ehrenreich, H; Maier, K; Merkler, D; Sättler, MB; Stadelmann, C	1
Brunner, R; Hess, K; Parzer, P; Resch, F; Schaefer, D; Schwab, S	1
Airas, L; Kataja, K; Kojo, T; Kotilainen, P; Kurki, T; Minn, H; Nuutila, P	1
Beiske, AG; Celius, EG; Eriksen, K; Heger, H; Hovdal, H; Jensen, D; Mellgren, SI; Midgard, R; Myhr, KM; Seland, JH; Wexler, A	1
Kattah, JC	1
Strupp, M	1
Atsumi, M; Hirose, N; Ishikawa, K; Nakasaka, Y; Saigoh, K; Yamada, A	1
Cohen, JA; Fisher, E; Fox, RJ; Lee, JC; Rudick, RA; Tkach, J	1
Brettschneider, J; Claus, A; Ecker, D; Elitok, E; Gold, R; Maier, M; Müller, S; Ostermann, B; Süssmuth, S; Tumani, H; Uttner, I; Zinser, C	1
Bosco, A; Bratina, A; Cazzato, G; Giuntini, D; Locatelli, L; Nasuelli, D; Rudick, RA; Tommasi, MA; Toncic, M; Zivadinov, R; Zorzon, M	1
Aarseth, JH; Myhr, KM; Nyland, HI; Torkildsen, O; Ulvestad, E; Vedeler, CA	1
Sellebjerg, F	1
Sloka, JS; Stefanelli, M	1
Brandt, T; Gross, A; Hohlfeld, R; Jahn, K; Nabauer, M; Strupp, M; Zingler, VC	1
Altenwerth, B; Block, F; Brandenburg, VM; Frank, RD; Nolden-Koch, M	1
Arnal, JF; Degano, B; Didier, A; Serrano, E; Têtu, L	1
Altmann, DR; Giovannoni, G; Grant, D; Jensen, CV; Keir, G; Lim, ET; Sellebjerg, F; Thompson, EJ	1
Jubelt, B; Mihai, C	1
Benetton, G; Di Vito, N; Fassio, F; Isoardo, G; Nobile, M	1
Bähr, M; Brück, W; Chan, A; Gärtner, J; Gold, R; König, FB; Koziolek, M; Linker, RA; Müller, GA; Paulus, W; Schilling, S	1
Billson, FA; Fraser, CL; Garrick, R; Graham, SL; Grigg, JR; Klistorner, A	1
Airas, LM; Kurki, T; Saraste, MH	1
Elovaara, I; Huhtala, H; Kuusisto, H; Lehtimäki, T; Paalavuo, R; Särkijärvi, S; Vilpo, J	1
Joseph, KR; Ney, JP	1
Iijima, M; Kato, H; Ohashi, T; Uchigata, M	1
Kutlu, C; Ozbabalik, D; Ozdemir, G; Ozkan, S; Uzuner, N	1
Balcer, LJ	1
Confavreux, C; Vukusic, S	1
Braszko, JJ; Drozdowski, W; Halicka, D; Kułakowska, A	1
Aristimuño, C; de Andrés, C; Fernández-Cruz, E; Martínez-Ginés, ML; Navarro, J; Sánchez-Ramón, S; Vigil, D	1
Czlonkowska, A; Czlonkowski, A; Koronkiewicz, M; Kruszewska, J; Kurowska, K; Mirowska-Guzel, DM; Skierski, J; Wicha, W	1
Fox, EJ	1
Al Saieg, N; Luzar, MJ	1
Ce, P; Coban, P; Gedizlioglu, M; Gelal, F; Ozbek, G	1
Funatogawa, I; Funatogawa, T; Ohashi, Y	1
Akdede, BB; Aksan, O; Idiman, E; Kösehasanogullari, G; Ozakbas, S	1
Deruaz, CA; Du Pasquier, RA; Schluep, M; Souza Lima, F; Spertini, F	1
Bergamaschi, R; Bogdanov, EI; Mikhaylov, IM; Moglia, A; Pichiecchio, A; Ravaglia, S	1
Kołczewska, A; Majewski, D; Puszczewicz, MJ; Tuchocka-Piotrowska, A	1
Catsman-Berrevoets, CE; Hintzen, RQ; Neuteboom, RF	1
Then Bergh, F	1
Bernat, A; Boscá, I; Casanova, B; Coret, F; Escutia, M; Pascual, AM	1
Chang, YC; Tsai, RK; Wu, WC	1
Katirji, B	1
Bielecki, B; Glabinski, A; Mazurek, A; Wolinski, P	1
Alstadhaug, K; Breivik, K; Rusic, Z	1
Beretta, S; Brusaferri, F; Ciccone, A; Galea, I; Protti, A; Spreafico, C	1
Kikuchi, S; Kishimoto, R; Niino, M; Sasaki, H; Sato, K; Tsuji, S; Yabe, I	1
Glabinski, A; Jalosinski, M; Karolczak, K; Mazurek, A	1
Bouillaguet, S; Cabaret, M; de Sèze, J; Dubois, G; Dujardin, K; Ferriby, D; Stojkovic, T; Vermersch, P; Zéphir, H	1
D'Adda, E; Ferrò, MT; Franciotta, D; Mainardi, E; Montanelli, A; Riccardi, T	1
Chan, A; Fischer, M; Gold, R; Haghikia, A; Hellwig, K; Müller, T; Schimrigk, S	1
Baker, AG	1
Hallpike, JF	1
Bosch, VV; Cook, SD; Dowling, PC	1
Abbruzzese, G; Gandolfo, C; Loeb, C	1
Ellison, GW; Fahey, JL; Frane, MV; Mickey, MR; Myers, LW; Spina, CA; Tourtellotte, WW	1
Chandra, RK; Pryse-Phillips, WE; Rose, B	1
Cook, S; Dowling, P; Hafstein, M; Ruderman, M; Troiano, R	1
Goas, JY; Marion, JL; Missoum, A	1
Delodovici, M; Mazzarello, P; Piccolo, G; Pinelli, P; Poloni, M; Rocchelli, B	1
Garvey, WF; Trotter, JL	1
Bernat, JL	1
Buckley, C; Kennard, C; Swash, M	1
Newman, PK; Saunders, M; Tilley, PJ	1
Anno, H; Koga, S; Miyata, E; Nomura, M; Suzumura, A; Yamamoto, H	1
Barré, J; Defer, GL; Degos, JD; Ledudal, P; Tillement, JP	1
Stankiewicz, A	1
Antonello, R; Bosco, A; Cargnelutti, D; Carraro, N; Cazzato, G; Mesiano, T; Monti, F; Torre, P	1
Bartolucci, AA; Burgard, S; Herman, PK; Kachelhofer, RD; Layton, BA; Whitaker, JN	1
Avanzini, G; Ciano, C; Eoli, M; La Mantia, L; Milanese, C; Riti, F; Salmaggi, A	1
Wray, SH	1
Woolf, K	1
Barkhof, F; Borm, GF; Frequin, ST; Hommes, OR; Lamers, KJ	2
Söderström, M	1
Beck, RW	3
Dufour, A; Eoli, M; La Mantia, L; Milanese, C; Nespolo, A; Salmaggi, A	1
Dufour, A; Eoli, M; La Mantia, L; Milanese, C; Salmaggi, A; Torri, V	1
Compston, DA; Kirk, PF; Petersen, MM; Williams, JD	1
Barkhof, F; Frequin, ST; Hommes, OR; Nauta, JJ; Scheltens, P; Tas, MW; Valk, J	1
Bohr, T	1
Cosman, F; Herbert, J; Lindsay, R; Nieves, J; Shen, V	1
Awerbuch, GI; Sandyk, R	1
Corbett, JJ	1
Griffiths, TD; Newman, PK	1
Kommerell, G	1
Lees, AJ; Scolding, NJ	1
Bloch, M; Gur, E; Shalev, A	1
Cesaro, P; Defer, G; Degos, JD	1
Funakawa, I; Hara, K; Terao, A; Yasuda, T	1
Khan, OA; Olek, MJ	1
Engelhardt, D; Hohlfeld, R	1
Bartleson, JD; Karnes, WE; Pineda, AA; Rodriguez, M	1
Goodkin, DE; Ross, JS; Rudick, RA	1
Beltrami, G; Bergamaschi, R; Callieco, R; Castelnovo, G; Cosi, V; Romani, A; Versino, M	1
Argentiero, V; Chiusole, M; Gallo, P; Piccinno, MG; Rizzotti, P; Sanzari, M; Sivieri, S; Tavolato, B	1
Barkhof, F; Borm, GF; Frequin, ST; Hommes, OR; Jongen, PJ; Lamers, KJ	1
Alam, SM; Kyriakides, T; Lawden, M; Newman, PK	1
Beck, RW; Brown, CH; Cleary, PA; Kaufman, DI; Kupersmith, MJ; Paty, DW; Trobe, JD	1
Silberberg, DH	1
Parker, SW	1
Mehdorn, E	1
Trobe, JD	1
Ebers, G; Johnson, K; Kaufman, D; Kupersmith, MJ; McFarland, H; Paty, DW; Reingold, S; Whitaker, J	1
Shetty, T	1
Gücüyener, K; Hasanoğlu, A; Oztürk, G; Tunaoğlu, S	1
Nelson, DA	3
Bergamaschi, R; Citterio, A; Cosi, V; Raiola, E; Versino, M	1
Albert, PS; Armstrong, M; Frank, JA; Maloni, H; Martin, R; McFarland, HF; McFarlin, DE; Smith, ME; Stone, LA	1
van der Hoeven, JH	1
Beck, RW; Trobe, JD	1
Chin, S; Fukazawa, T; Harada, T; Matsuda, H; Miyagishi, R; Moriwaka, F; Ohashi, T; Yoshida, K	1
Coles, A; Compston, A; Hale, G; Isaacs, J; Moreau, T; Waldmann, H; Wing, M	1
Baskerville, J; Issa, M; Weinshenker, BG	1
Christiansen, P; Jensen, CV; Nordenbo, A; Ravnborg, M; Schreiber, K; Szpirt, W; Sørensen, PS; Wanscher, B	1
Correa, N; Dencoff, JE; Ford, CC; Reiners, M; Rosenberg, GA	1
Bernardi, G; Gualdi, GF; Iannetti, P; Marciani, MG; Raucci, U; Spalice, A; Spanedda, F; Trasimeni, G	1
Levi, L	1
Ozawa, K; Saida, T	1
Sato, T	1
Crockard, AD; Droogan, AG; Hawkins, SA; Treacy, MT	2
Khan, OA	1
Janković, S; Kendereski, A; Lević, Z; Mavra, M; Micić, D; Nikolić, J; Sokić, D; Stojisavljević, N	1
Codina, A; Comabella, M; Montalban, X; Nos, C; Rio, J; Rovira, A; Tintoré, M	1
Orrell, RW	1
Hartmann, M; Hohlfeld, R; Holler, E; Scheller, A; Spuler, S; Voltz, R; Wick, M; Yousry, T	1
Berry, I; Brochet, B; Cabanis, E; Clanet, M; Confavreux, C; Edan, G; Froment, JC; Gandon, JM; Iba-Zizen, MT; Lai, HM; Lubetzki, C; Lyon-Caen, O; Miller, D; Moseley, I; Rolland, Y; Sabouraud, O	1
Barkhof, F; Polman, C	1
Barnes, D; Britton, T; Brown, P; Farmer, S; Francis, DA; Frankel, J; Hughes, RA; Katifi, H; Morris, RW; Perkin, GD; Rudge, P; Swash, M; Wade-Jones, O	1
Gray, IA; Hughes, RA; Lee, A; Pitzalis, C; Sharrack, B	1
Bastianello, S; Bozzao, L; Colleluori, A; Fieschi, C; Galgani, S; Gasperini, C; Horsfield, MA; Koudriavtseva, T; Millefiorini, E; Pozzilli, C; Thompson, AJ	1
De Keyser, J; Zwanikken, C	1
Tremlett, H	1
Melms, A; Reinhardt, C; Reul, JM	1
Bergamaschi, R; Cosi, V; Franciotta, D; Piccolo, G; Zardini, E	1
Chen, JM; Commins, DJ	1
Balashov, KE; Hafler, DA; Khoury, SJ; Smith, DR; Weiner, HL	1
Enoki, M; Sawaishi, Y; Takada, G; Takahashi, I; Takeda, O	1
Corsini, E; Dufour, A; Gelati, M; Lamperti, E; Milanese, C; Nespolo, A; Salmaggi, A; Venegoni, E	1
Barkhof, F; Frequin, ST; Hommes, OR; Jongen, PJ	1
Crockard, AD; Droogan, AG; Hawkins, SA; McNeill, TA; Treacy, MT	1
Nakamura, Y; Takahashi, M; Yagi, Y	1
Ciusani, E; Corsini, E; Dufour, A; Frigerio, S; Gelati, M; Massa, G; Milanese, C; Nespolo, A; Salmaggi, A	1
Drulović, J; Filipović, SR; Lević, Z; Stojsavljević, N	1
Stapel, S; van den Berg, JS; van der Valk, PG; van Eikema Hommes, OR; Wuis, EW	1
Crockard, AD; Droogan, AG; Hawkins, SA; McMillan, SA	1
Ando, M; Ando, Y; Obayashi, K; Uchino, M; Yamashita, T	1
Bastianello, S; Bozzao, L; Fieschi, C; Galgani, S; Gasperini, C; Horsfield, MA; Koudriavtseva, T; Millefiorini, E; Paolillo, A; Pozzilli, C	1
Brulport, V; Cerisier, A; Dacosta, A; Deluc, D; Isaaz, K; Rousset, H	1
Hirade, S; Inoue, H; Nagasawa, H; Takashima, S	1
Brush, M; Burns, WH; Burt, RK; Cohen, B; Davis, FA; Fishman, M; Goolsby, C; Gordon, LI; Karlin, KH; Keever-Taylor, C; Lobeck, L; Rosen, S; Russell, EJ; Stefoski, D; Terry, C; Traynor, AE	1
Bulduklar, S; Cansu, K; Gündüz, K; Saatçi, I	1
Gayo, A; Gutiérrez, C; Lahoz, C; Mozo, L; Suárez, A; Tuñon, A	1
Aguglia, U; Bono, F; Fera, F; Gambardella, A; Oliveri, RL; Pardatscher, K; Quattrone, A; Russo, C; Sibilia, G; Valentino, P; Zappia, M	1
Briceño, F; García-Guijo, C; García-Téllez, MD; Jiménez-Arjona, MJ; Rubio-Esteban, G	1
Hebel, JR; Khan, OA	1
Heindl, N; Kirchner, H; Trillenberg, P; Wandinger, KP; Wessel, K	1
Oliveri, RL; Quattrone, A; Romeo, N; Russo, C; Sibilia, G; Valentino, P	1
Gogol, D; Goodkin, DE; Kinkel, RP; Neilley, L; Perryman, JE; Secic, M; Uccelli, MM; VanderBrug-Medendorp, S; Weinstock-Guttman, B	1
Fukaura, H; Hafler, DA; Khoury, SJ; Smith, DR; Takashima, H; Weiner, HL	1
Boylan, MT; Crockard, AD; Droogan, AG; Hawkins, SA; McMillan, SA	1
Bain, C; Beck, S; Coyte, PC; Guthrie, S; O'Connor, P; Robson, LS	1
Frederiksen, JL; Nielsen, PM; Olesen, J; Sellebjerg, F	2
Miller, DH	1
Luscombe, DK; Tremlett, HL; Wiles, CM	1
Angulo, T; Campos-Castelló, J; Careaga, J; de Santos, T; Martín, S; Sánchez-Calderón, M	1
de Reus, HP; Jongen, PJ; Lamers, KJ	1
Alvarez-Cermeño, JC; González-Porqué, P; Luján, S; Masjuan, J; Roldán, E; Villar, LM	1
Barkhof, F; Polman, CH; Truyen, L; van Oosten, BW	1
Brush, M; Burns, WH; Burt, RK; Cohen, B; Davis, FA; Fishman, M; Goolsby, C; Karlin, KH; Keever-Taylor, C; Lobeck, L; Mujias, S; Pope, R; Rosen, S; Rowlings, P; Schroeder, J; Stefoski, D; Terry, C; Traynor, AE; Vesole, D; Villa, M	1
Dastidar, P; Elovaara, I; Lällä, M; Lehtimäki, T; Spåre, E	1
Beck, RW; Katz, B; Trobe, JD	1
Jongen, PJ; Lagerwerf, AJ; Maes, RA; Swolfs, A; van Eikema Hommes, OR; van Ooijen, RD; Verwey-van Wissen, CP; Vree, TB	1
Carter, JL; Cohen, JA; Kinkel, RP; Schwid, SR	1
Shimada, M; Takano, T; Watanabe, N; Yamano, T	1
Okamoto, K; Sotomatsu, A; Tanaka, M; Yoshida, T	1
Heitjan, DF	1
Bergamaschi, R; Cosi, V; Desina, G; Franciotta, D; Martino, G; Zardini, E	1
Berger, E; Rumbach, L	1
Gruszka, E; Paradowski, B; Pokryszko, A	1
Jongen, PJ; Lagerwerf, AJ; Verwey-van Wissen, CP; Vree, TB	1
Breningstall, GN	1
Rieckmann, P; Toyka, KV	1
Abramsky, O; Karussis, D; Weiner, HL	1
Dawson, DM; Hafler, DA; Hohol, MJ; Khoury, SJ; Olek, MJ; Orav, EJ; Stazzone, L; Weiner, HL	1
Olek, MJ	1
Mason, B; Shah, AK; Tselis, A	1
Cendes, F; Damasceno, BP; Kobayashi, E; Maciel, EP; Netto, JR; Reis, F; Zanardi, Vde A	1
Beck, RW; Cole, SR; Gal, RL; Garovoy, J; Hauser, SL; Kip, KE; Lincoln, R; Long, DT; Moke, PS; Oksenberg, JR	1
Antel, JP; Forman, S; Kashyap, A; Lund, BT; McSweeney, P; Nash, R; Openshaw, H; Stuve, O; Weiner, LP	1
Glaser, JS; Leiba, H; Schatz, NJ; Siatkowski, RM	1
Christiansen, M; Frederiksen, JL; Jensen, J; Sellebjerg, F	1
Pender, MP	1
Jennings, A; McCluskey, PJ; Wakefield, D	1
Barnes, D; Beck, G; Béthoux, F; Block, V; Durelli, L; LaMantia, L; Lee, JC; Miller, DM; Rudick, RA; Sellebjerg, F; Weinstock-Guttman, B	1
Ichikawa, Y; Igarashi, O; Ikeda, K; Iwasaki, Y	1
Friedman, DI	1
Endo, M; Saitoh, S; Sudo, A	1
Beyer, M; Grieger, U; Haas, J; Wagenknecht, B; Waiczies, S; Weller, M; Wendling, U; Zipp, F	1
Brusaferri, F; Candelise, L; Citterio, A; Ciucci, G; Filippini, G; Midgard, R; Sibley, WA	1
Atkinson, R; Forman, S; Kashyap, A; Lund, BT; Openshaw, H; Sniecinski, I; Weiner, LP	1
Lee, AG; Schiffman, JS; Singh, S; Tang, RA; Wong, GG	1
Gold, R; Jung, S; Leussink, VI; Merschdorf, U; Toyka, KV	1
Kira, J; Ochi, H	1
Aidi, S; Biousse, V; Bousser, MG; Chaunu, MP	1
Andreoni, L; Bergamaschi, R; Cosi, V; Franciotta, D; Furlan, R; Martino, G; Zardini, E	1
Hashimoto, Y; Tashima, K; Uchino, M; Uyama, E; Yonehara, T	1
Kiefer, G; Rieckmann, P	1
Bash, CN; Frank, JA; Leist, TP; McFarland, HF; Ostuni, JL; Richert, ND	1
Kostadinova, II; Manova, MG; Rangelov, AA	1
Knauth, M; Mohr, A; Schwarz, S; Storch-Hagenlocher, B; Wildemann, B	1
Akçay, F; Aksoy, H; Keles, MS; Sen, N; Taysi, S	1
Fauchard-Renard, C; Hannequin, D; Mihout, B; Miret, N; Renard, JF; Weber, J	1
Almany, A; Berkovitz, E; Dishon, S; Edelstein, H; Miller, A; Steinmetz, D	1
Adèr, HJ; Barkhof, F; Killestein, J; Polman, CH; Rep, MH; Roos, MT; van Lier, RA	1
Akcay, F; Aksoy, H; Polat, F; Sait Keles, M; Sen, N; Taysi, S	1
Jensen, CV; Ransohoff, RM; Sellebjerg, F; Strieter, RM; Sørensen, TL	1
Brochet, B	1
Beguin, C; Carton, H; D'Hooghe, MB; Dooms, G; Lissoir, F; Sindic, CJ; van de Wyngaert, FA	1
Cendrowski, W	2
Barberà, N; Barrau, MA; Brieva, L; Espejo, C; Martínez-Cáceres, EM; Montalban, X	1
Brighina, F; Buffa, D; Conte, S; Fierro, B; La Bua, V; Piazza, A; Salemi, G; Savettieri, G	1
Malin, JP; Ossege, LM; Patzold, T; Schwengelbeck, M; Sindern, E	1
Garred, P; Giovannoni, G; Hand, A; Jensen, CV; Madsen, HO; Sellebjerg, F	1
Baraczka, K; Lakos, G; Sipka, S	1
Elovaara, I; Pirttilä, T	1
Bernardi, G; Boiardi, A; Corsini, E; De Rossi, M; Gelati, M; Masini, L; Massa, G; Salmaggi, A	1
Bentley, PI; Kimber, T; Schapira, AH	1
Mayr, WT; Rodriguez, M	1
Abel, R; Bernat, JL; Nelson, DA	1
Bernat, JL; Margolis, G; Nordgren, RE; Sadowsky, CH; Vincent, FM	1
Jedlicka, P; Kocinová, F; Kupka, J	1
McDonald, E	1
Gerling, J; Kommerell, G	1
Funakawa, I; Terao, A; Yasuda, T	1
Bittencourt, PR; Gorz-Reinhardt, AM; Gracia, CM; Oliveira, TV	1
Aguayo, F; Alvarez, C; Berciano, J; Garrido, JC; Miró, J; Pascual, J; Polo, JM	1
Barkhof, F; Frequin, ST; Hommes, OR; Lamers, K; Scheltens, P; Valk, J; van Geel, WJ	1
Bansil, S; Bielory, L; Cook, SD; Dowling, PC; Jotkowitz, A; Mehta, PD; Oleske, J; Rohowsky-Kochan, C; Troiano, R	1
Barkhof, F; Frequin, ST; Hommes, OR; Lamers, KJ	1
Boulesteix, JM; Dumas, M; Hugon, J; Poser, CM; Salle, JY; Tabaraud, F; Vallat, JM	1
Wilkinson, HA	1
Heun, R; Rüttinger, H; Schimrigk, K; Sliwka, U	1
Kendall, BE; MacManus, DG; McDonald, WI; Miller, DH; Moore, SG; Morrissey, SP; Moseley, IF; Thompson, AJ	1
Hayashi, F; Imamura, K; Suzumura, A	1
Beer, S; Kesselring, J	1
Anderson, MM; Beck, RW; Buckley, EG; Cleary, PA; Corbett, JJ; Kaufman, DI; Keltner, JL; Kupersmith, MJ; Miller, NR; Shults, WT	1
Hughes, RA	1
Bertelsmann, FW; Polman, CH; van Dongen, MM	1
Barkhof, F; Hommes, OR; Scheltens, P; Valk, J	1
Burnham, JA; Dreisbach, J; Murray, RS; Wright, RR	1
Koetsier, JC; Netelenbos, JC; Polman, CH; Teule, GJ; van der Wiel, HE	1
Compston, A; Kirk, P	1
Fishman, PS; Panitch, HS; Tippett, DS	1
Kir'iakov, VA; Neretin, VIa; Sapfirova, VA	1
Amado, JA; Berciano, J; López-Cordovilla, JJ; Miró, J; Pesquera, C	1
Anderson, TJ; Donaldson, IM; George, PM; Sheat, JM	1
Bodiguel, E; Collard, M; Dietemann, JL; Rumbach, L; Tranchant, C; Warter, JM	1
Carroll, DJ; Catz, I; Jeffrey, VM; Warren, KG	1
Carroll, DJ; Catz, I; Warren, KG	1
Carter, JL; Rodriguez, M	1
Emser, W; Heun, R; Schimrigk, K	1
Rivera, VM	1
Campi, A; Corridori, F; Eoli, M; La Mantia, L; Milanese, C; Nespolo, A; Salmaggi, A; Scaioli, V	1
Ferner, R; Kennard, C; Loizou, LA; Perkin, GD; Roche, S; Shepherd, DI; Summers, B; Swash, M; Thompson, AJ; Yuill, GM	1
Abarbanel, JM; Badarna, S; Bearman, JE; Herishanu, YO; Sarov, B; Segal, S	1
Adeleine, P; Neuschwander, P; Nighoghossian, N; Tremisi, P; Trouillas, P	1
Ellison, GW; Frane, MV; Graves, MC; Holevoet-Howson, MI; Lerner, CD; Mickey, MR; Myers, LW; Pettler-Jennings, P; Syndulko, K; Tourtellotte, WW	1
Ochudło, S	1
Compston, DA; Johnson, G; Kesselring, J; MacManus, DG; McDonald, WI; Miller, DH; Milligan, NM; Scolding, N	1
Sanders, EA	1
Menken, M	1
Baumhefner, RW; Shapshak, P; Staugaitis, A; Syndulko, K; Tourtellotte, WW	1
Brooks, BR; Young, FK	1
Campbell, AK; Compston, DA; Gibbs, J; Hughes, PJ; McBroom, V; Milligan, NM; Morgan, BP	1
Barnes, MP; Bateman, DE; Cleland, PG; Dick, DJ; Newman, PK; Saunders, M; Tilley, PJ; Walls, TJ	1
Ellison, GW; Lee, M; Myers, LW; Shapshak, P; Staugaitis, SM; Tourtellotte, WW	1
Bindoff, L; Lyons, PR; Newman, PK; Saunders, M	1
Canu, C; Carta, F; Datti, R; Guiducci, G; Pisani, R; Silvestro, C	1
Davison, AN	1
Cartier, L; Verdugo, R	1
Hoogstraten, MC; Minderhoud, JM	1
Compston, DA; Milligan, NM; Newcombe, R	1
Ellison, GW; Myers, LW; Nuwer, MR; Packwood, JW	1
Lyons, PR; Newman, PK; Saunders, M	1
Bixenman, WW; Buchsbaum, HW	1
Compston, A	1
Hachinski, V	1
Bernardi, S; Bozzao, L; Carolei, A; Fieschi, C; Pantano, P; Pozzilli, C	1
Baggio, GF; Barile, C; Bergamasco, B; Bergamini, L; Cocito, D; Delsedime, M; Durelli, L; Gusmaroli, G; Perla, F; Riccio, A	1
Fleet, WS; Watson, RT	1
Hamaguchi, K; Ohno, R; Sowa, K; Tanaka, H; Watanabe, Y	1
Harada, K; Sugita, T; Sumi, K; Takizawa, K; Tanaka, Y	1
Konishi, T; Nishitani, H; Saida, T	1
Harrer, S; Krieger, O; Rybiczka, R	1
Sjö, O; Smith, T; Zeeberg, I	1
Beppu, K; Habara, S; Matsuda, H; Morimoto, T; Nagao, H; Sano, N; Shoda, T; Takahashi, M	1
Jacquillat, C; Mazalton, A; Piot, C; Raymondeaud, C; Sigwald, J	1
Brogi, L; Gasperini, GF; Girelli Bruni, E; Monaco, V; Sbarbaro, V; Zardini, GB	1
Hanák, L; Zouhar, A	1
Hrazdira, CL; Mandzjuk, B; Skálová, M	1
Nelson, DA; Thomas, RB; Vates, TS	1
Abrahamson, HA	1
De Vito, SJ; Mannarelli, AA	1
Beck, RH	1
Delzanno, GB; Jann, G	1
Giles, CL	1
Goldstein, NP; Mattox, VR; McGuckin, WF; McKenzie, BF	1
Ringer, WA	1
Giunta, A; Palchetti, R; Scarpelli, PT; Tortoli, V	1

Reviews

80 review(s) available for methylprednisolone and MS (Multiple Sclerosis)

Article	Year
[Pediatric therapeutic options in autoimmune neurologic diseases]. Medicina, 2022, Aug-30, Volume: 82 Suppl 3 Topics: Autoimmune Diseases; Child; Encephalomyelitis, Acute Disseminated; Humans; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica	2022
A current understanding of multiple sclerosis. JAAPA : official journal of the American Academy of Physician Assistants, 2020, Volume: 33, Issue:2 Topics: Brain; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prognosis; Pulse Therapy, Drug; Risk Factors; Vision Disorders	2020
Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes. Multiple sclerosis and related disorders, 2020, Volume: 46 Topics: Adrenal Cortex Hormones; COVID-19; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis	2020
Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood. Archives of disease in childhood, 2022, Volume: 107, Issue:3 Topics: Adolescent; Anti-Inflammatory Agents; Brain; Child; Demyelinating Diseases; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Occupational Therapy; Recurrence	2022
Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials. PloS one, 2017, Volume: 12, Issue:11 Topics: Administration, Oral; Adult; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Publication Bias; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome	2017
Neuromyelitis optica spectrum disorder presenting in an octogenarian. BMJ case reports, 2018, Sep-08, Volume: 2018 Topics: Aged, 80 and over; Aquaporin 4; Azathioprine; Brain Stem; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Plasma Exchange; Sjogren's Syndrome; Spinal Cord	2018
Incorporating Clinical Practice Guidelines and Quality Measures Into High-Quality Cost-Effective Care for Patients With Multiple Sclerosis. Continuum (Minneapolis, Minn.), 2019, Volume: 25, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Cost-Benefit Analysis; Female; Humans; Methylprednisolone; Multiple Sclerosis; Practice Guidelines as Topic; Quality of Health Care	2019
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review. United European gastroenterology journal, 2019, Volume: 7, Issue:6 Topics: Administration, Intravenous; Adult; Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Disease; Humans; Liver Function Tests; Methylprednisolone; Middle Aged; Multiple Sclerosis	2019
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature. The Netherlands journal of medicine, 2013, Volume: 71, Issue:4 Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence	2013
Optic neuritis and the evaluation of visual impairment in multiple sclerosis. Continuum (Minneapolis, Minn.), 2013, Volume: 19, Issue:4 Multiple Topics: Adult; Anti-Inflammatory Agents; Brain Diseases; Diagnosis, Differential; Evoked Potentials, Visual; Female; Humans; Magnetic Resonance Imaging; Medical History Taking; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Optic Neuritis; Tomography, Optical Coherence; Vision Disorders	2013
[Clinically isolated syndrome]. Der Nervenarzt, 2013, Volume: 84, Issue:10 Topics: Adult; Brain; Demyelinating Diseases; Diagnosis, Differential; Glatiramer Acetate; Guideline Adherence; Humans; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Optic Neuritis; Peptides; Prognosis; Pulse Therapy, Drug; Spinal Cord; Young Adult	2013
[Neuromyelitis optica]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Oct-15, Volume: 133, Issue:19 Topics: Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Astrocytes; Autoantibodies; Azathioprine; Diagnosis, Differential; Humans; Immunologic Factors; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Rituximab	2013
Multiple sclerosis and pregnancy in the 'treatment era'. Nature reviews. Neurology, 2015, Volume: 11, Issue:5 Topics: Analgesia, Epidural; Analgesia, Obstetrical; Breast Feeding; Contraindications; Counseling; Female; Humans; Immunoglobulins, Intravenous; Infertility, Female; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Preconception Care; Pregnancy; Pregnancy Complications; Prenatal Care; Reproductive Techniques, Assisted; Risk Factors; Secondary Prevention	2015
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Human vaccines & immunotherapeutics, 2015, Volume: 11, Issue:12 Topics: Autoimmune Diseases; Child; Chorea; Cyclophosphamide; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Immunotherapy; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Natalizumab; Nervous System; Neurodegenerative Diseases; Neuromyelitis Optica; Obsessive-Compulsive Disorder; Plasma Exchange; Rituximab; Streptococcal Infections; Tourette Syndrome	2015
[Demyelinating diseases in children with acute neurological symptoms]. Ugeskrift for laeger, 2015, Dec-07, Volume: 177, Issue:50 Topics: Child; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica; Neuroprotective Agents; Optic Neuritis	2015
Cerebral venous sinus thrombosis in the patient with multiple sclerosis associated with congenital antithrombin deficiency. Rinsho shinkeigaku = Clinical neurology, 2016, 04-28, Volume: 56, Issue:4 Topics: Adult; Antithrombins; Codon, Nonsense; Diffusion Magnetic Resonance Imaging; Fibrin; Heterozygote; Humans; Hyperhomocysteinemia; Male; Methylprednisolone; Multiple Sclerosis; Risk Factors; Sinus Thrombosis, Intracranial; Spinal Puncture	2016
Pediatric Demyelination. Continuum (Minneapolis, Minn.), 2016, Volume: 22, Issue:3 Topics: Child; Child, Preschool; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica	2016
Long-term experience with induction treatment regimens in multiple sclerosis. Journal of the neurological sciences, 2009, Feb-01, Volume: 277 Suppl 1 Topics: Adult; Central Nervous System; Clinical Protocols; Drug Therapy, Combination; Early Diagnosis; Female; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Treatment Outcome	2009
Multiple sclerosis: from cure to care. Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2009, Volume: 71, Issue:5 Topics: Environment; Genetic Predisposition to Disease; Humans; Methylprednisolone; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Quality of Life; Severity of Illness Index	2009
Optic neuritis associated with adalimumab in the treatment of uveitis. Ocular immunology and inflammation, 2010, Volume: 18, Issue:6 Topics: Adalimumab; Adjuvants, Immunologic; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Brain; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Interferon beta-1a; Interferon-beta; Iridocyclitis; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Tumor Necrosis Factor-alpha; Uveitis; Visual Fields	2010
Acute disseminated encephalomyelitis (ADEM). Journal of neuroimmunology, 2011, Volume: 231, Issue:1-2 Topics: Animals; Diagnostic Imaging; Encephalomyelitis, Acute Disseminated; Humans; Methylprednisolone; Multiple Sclerosis	2011
Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects. Internal medicine journal, 2002, Volume: 32, Issue:11 Topics: Adjuvants, Immunologic; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Disease Progression; Genetic Predisposition to Disease; Glatiramer Acetate; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Interferon-beta; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Mitoxantrone; Models, Theoretical; Multiple Sclerosis; Peptides	2002
Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology, 2002, Sep-24, Volume: 59, Issue:6 Suppl 3 Topics: Clinical Trials as Topic; Disease Progression; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Peptides	2002
[Steroid therapy for multiple sclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:8 Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pulse Therapy, Drug	2003
[Diagnosis and treatment of multiple sclerosis. Update, 2003]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Acute Disease; Adjuvants, Immunologic; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Controlled Clinical Trials as Topic; Cross-Over Studies; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Longitudinal Studies; Methylprednisolone; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Natalizumab; Peptides; Pilot Projects; Prospective Studies; Recurrence; Time Factors	2003
[Demyelinating disease]. Ryoikibetsu shokogun shirizu, 2003, Issue:40 Topics: Adrenoleukodystrophy; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Autoimmunity; Benzodiazepines; Diffuse Cerebral Sclerosis of Schilder; Encephalomyelitis, Acute Disseminated; Humans; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Myelin Proteolipid Protein; Neuromyelitis Optica; Olanzapine; Pirenzepine; Pulse Therapy, Drug; Selective Serotonin Reuptake Inhibitors; T-Lymphocytes	2003
[Treatment of optic neuritis]. Nederlands tijdschrift voor geneeskunde, 2004, Jan-10, Volume: 148, Issue:2 Topics: Brain; Diagnosis, Differential; Humans; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Optic Neuritis; Risk Factors; Treatment Outcome	2004
[Aggressive multiple sclerosis. Definition and specific therapeutic indication]. Presse medicale (Paris, France : 1983), 2004, Feb-14, Volume: 33, Issue:3 Topics: Adjuvants, Immunologic; Adult; Analgesics; Anti-Inflammatory Agents; Clinical Trials as Topic; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Patient Selection; Placebos; Risk Assessment; Risk Factors; Time Factors	2004
Non-MS recurrent demyelinating diseases. Clinical neurology and neurosurgery, 2004, Volume: 106, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Atrophy; Brain; Demyelinating Diseases; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Recurrence; Reflex, Abnormal; Tongue	2004
The use of interferon beta in relapsing-remitting multiple sclerosis. Archives of disease in childhood, 2004, Volume: 89, Issue:8 Topics: Adjuvants, Immunologic; Brain; Child; Female; Glucocorticoids; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Recurrence; Treatment Outcome	2004
Deep vein thrombosis after intravenous immunoglobulins associated with methylprednisolone. Thrombosis and haemostasis, 2004, Volume: 92, Issue:3 Topics: Adult; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Multiple Sclerosis; Venous Thrombosis	2004
[Allergic skin rashes by methylprednisolone in a case with multiple sclerosis]. Rinsho shinkeigaku = Clinical neurology, 2004, Volume: 44, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Drug Eruptions; Female; Humans; Methylprednisolone; Multiple Sclerosis; Pulse Therapy, Drug	2004
[Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with relapsing multiple sclerosis]. No to shinkei = Brain and nerve, 2005, Volume: 57, Issue:1 Topics: Brain; Humans; Hyponatremia; Hypothalamus; Inappropriate ADH Syndrome; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Pulse Therapy, Drug; Recurrence	2005
Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis. Danish medical bulletin, 2004, Volume: 51, Issue:2 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antigens, CD; Autoantibodies; Brain; Glucocorticoids; HLA-DR Antigens; Humans; Immunoglobulins; Inflammation; Methylprednisolone; Multiple Sclerosis; Spinal Cord; T-Lymphocytes	2004
The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2005, Volume: 11, Issue:4 Topics: Cell Adhesion Molecules; Humans; Methylprednisolone; Models, Immunological; Multiple Sclerosis; Neuroprotective Agents; T-Lymphocytes; Transcription, Genetic	2005
Post-infectious encephalomyelitis. Current neurology and neuroscience reports, 2005, Volume: 5, Issue:6 Topics: Brain; Central Nervous System Viral Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Neuroprotective Agents; Spinal Cord	2005
Clinical practice. Optic neuritis. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Adjuvants, Immunologic; Adult; Brain; Diagnosis, Differential; Female; Glucocorticoids; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Optic Nerve; Optic Neuritis; Practice Guidelines as Topic; Risk; Visual Acuity	2006
[Multiple sclerosis and pregnancy]. Revue neurologique, 2006, Volume: 162, Issue:3 Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Breast Feeding; Central Nervous System Agents; Contraindications; Delivery, Obstetric; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Models, Neurological; Multiple Sclerosis; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Prospective Studies; Puerperal Disorders; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index	2006
Management of worsening multiple sclerosis with mitoxantrone: a review. Clinical therapeutics, 2006, Volume: 28, Issue:4 Topics: Anti-Inflammatory Agents; Clinical Trials, Phase II as Topic; Disease Progression; Humans; Immunosuppressive Agents; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Patient Selection; Randomized Controlled Trials as Topic	2006
Corticosteroids for the long-term treatment in multiple sclerosis. The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1 Topics: Adrenal Cortex Hormones; Disease Progression; Humans; Long-Term Care; Methylprednisolone; Multiple Sclerosis; Prednisolone; Randomized Controlled Trials as Topic	2008
New treatments for multiple sclerosis. British journal of hospital medicine, 1980, Volume: 23, Issue:1 Topics: Adrenocorticotropic Hormone; Antilymphocyte Serum; Azathioprine; Desensitization, Immunologic; Dietary Fats; Glutens; Humans; Immunosuppressive Agents; Levamisole; Linoleic Acids; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Prednisolone; Transfer Factor	1980
Intraspinal steroid therapy. Neurology, 1981, Volume: 31, Issue:2 Topics: Glycols; Humans; Injections; Injections, Spinal; Intervertebral Disc Displacement; Meningitis; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis; Pain; Steroids	1981
Optic neuritis: guidelines. Current opinion in neurology, 1995, Volume: 8, Issue:1 Topics: Clinical Protocols; Disease Progression; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisolone; Randomized Controlled Trials as Topic; Vision Disorders	1995
Steroids in multiple sclerosis. Journal of clinical pharmacy and therapeutics, 1994, Volume: 19, Issue:4 Topics: Cost-Benefit Analysis; Drug Administration Schedule; Drug Delivery Systems; Drug Evaluation; Humans; Methylprednisolone; Multiple Sclerosis; Recurrence	1994
[Corticoids and multiple sclerosis]. Annales de medecine interne, 1994, Volume: 145 Suppl 2 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Humans; Methylprednisolone; Multiple Sclerosis	1994
The use of brain magnetic resonance imaging in multiple sclerosis. Archives of neurology, 1994, Volume: 51, Issue:5 Topics: Brain; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Nervous System Diseases; Neuropsychological Tests; Organometallic Compounds; Pentetic Acid	1994
[What is new in neuro-ophthalmology? Diagnosis, therapy and patient education in optic nerve neuritis]. Klinische Monatsblatter fur Augenheilkunde, 1993, Volume: 203, Issue:3 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Patient Education as Topic; Visual Acuity; Visual Fields	1993
Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology, 1996, Volume: 46, Issue:6 Topics: Autoimmune Diseases; Azathioprine; Brain Stem; Clinical Trials, Phase III as Topic; Cyclosporine; Disease Progression; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Placebos; Plasma Exchange; Pyramidal Tracts; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Failure	1996
[Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials]. Rinsho shinkeigaku = Clinical neurology, 1995, Volume: 35, Issue:12 Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Humans; Immunosuppressive Agents; Immunotherapy; Interferons; Magnetic Resonance Imaging; Methylprednisolone; Monitoring, Physiologic; Multiple Sclerosis	1995
[Multiple sclerosis: update on current therapies]. Rinsho shinkeigaku = Clinical neurology, 1995, Volume: 35, Issue:12 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; CD4 Antigens; Cell Adhesion Molecules; Humans; Immunosuppressive Agents; Immunotherapy; Interferons; Methylprednisolone; Multiple Sclerosis; Recombinant Proteins	1995
Multiple sclerosis: a review of existing therapy and future prospects. JPMA. The Journal of the Pakistan Medical Association, 1996, Volume: 46, Issue:1 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; Cyclosporins; Female; Forecasting; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis; Research	1996
Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future. Multiple sclerosis (Houndmills, Basingstoke, England), 1996, Volume: 1, Issue:6 Topics: Dose-Response Relationship, Drug; Forecasting; Humans; Methylprednisolone; Multiple Sclerosis; Treatment Outcome	1996
[Severe coronary events and corticoids bolus. An update apropos of 3 new cases]. Archives des maladies du coeur et des vaisseaux, 1997, Volume: 90, Issue:9 Topics: Adult; Coronary Vasospasm; Fatal Outcome; Glomerulonephritis; Glucocorticoids; Humans; IgA Vasculitis; Injections, Jet; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myocardial Ischemia; Risk Factors	1997
Choosing drug therapy for multiple sclerosis. An update. Drugs, 1998, Volume: 56, Issue:4 Topics: Anti-Inflammatory Agents; Disease Progression; Forecasting; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferons; Methylprednisolone; Multiple Sclerosis; Peptides	1998
The optic neuritis treatment trial: implications for clinicians. Seminars in ophthalmology, 1995, Volume: 10, Issue:3 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Clinical Trials as Topic; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisolone; Randomized Controlled Trials as Topic	1995
Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders. Journal of neuroimmunology, 1999, Jul-01, Volume: 98, Issue:1 Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Multiple Sclerosis; Recurrence; Treatment Failure; Treatment Outcome	1999
[New therapeutic strategies in multiple sclerosis]. La Revue de medecine interne, 1999, Volume: 20 Suppl 3 Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Brain; Clinical Trials as Topic; Disease Progression; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Neuroprotective Agents; Peptides; Polymers; Recurrence	1999
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]. European neurology, 1999, Volume: 42, Issue:3 Topics: Adjuvants, Immunologic; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Peptides; Pulse Therapy, Drug	1999
Multiple sclerosis vs Lyme disease: a case presentation to a discussant and a review of the literature. Multiple sclerosis (Houndmills, Basingstoke, England), 1999, Volume: 5, Issue:6 Topics: Diagnosis, Differential; Humans; Immunoglobulin G; Lyme Disease; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Tomography, X-Ray Computed; Vitamin B 12	1999
Neurology. 4: Multiple sclerosis. The Medical journal of Australia, 2000, Jun-05, Volume: 172, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Autoimmune Diseases; Central Nervous System Diseases; Diagnostic Imaging; Female; Humans; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Patient Education as Topic	2000
A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Multiple sclerosis (Houndmills, Basingstoke, England), 2000, Volume: 6, Issue:4 Topics: Disability Evaluation; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Placebos	2000
Multiple sclerosis simulating a mass lesion. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2000, Volume: 20, Issue:3 Topics: Adult; Blood Sedimentation; Brain; Brain Diseases; Demyelinating Diseases; Dexamethasone; Female; Glucocorticoids; Hemianopsia; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Paresis; Pregnancy; Stereotaxic Techniques	2000
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. The Cochrane database of systematic reviews, 2000, Issue:4 Topics: Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Glucocorticoids; Humans; Methylprednisolone; Multiple Sclerosis; Randomized Controlled Trials as Topic	2000
[Multiple sclerosis]. Ryoikibetsu shokogun shirizu, 2000, Issue:31 Topics: Animals; Autoimmunity; Diagnosis, Differential; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Myelin Proteins; Peptides; Prednisolone; Prognosis; T-Lymphocytes	2000
Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids. Headache, 1999, Volume: 39, Issue:8 Topics: Adult; Cerebral Veins; Dose-Response Relationship, Drug; Female; Glucocorticoids; Headache; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Spinal Puncture; Venous Thrombosis	1999
[Optic neuritis. First manifestation of multiple sclerosis? Current diagnostic and therapeutic strategies]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:3 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Diagnosis, Differential; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Placebos; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Time Factors	2001
[Guidelines of the consensus conference on multiple sclerosis]. Revue neurologique, 2001, Volume: 157, Issue:6-7 Topics: Combined Modality Therapy; Diagnosis, Differential; Humans; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Patient Care Team; Predictive Value of Tests; Prognosis	2001
[Therapeutic indications for acute episodes of multiple sclerosis]. Revue neurologique, 2001, Volume: 157, Issue:8-9 Pt 2 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Follow-Up Studies; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Randomized Controlled Trials as Topic; Treatment Outcome	2001
[Therapeutic potential of interferon beta-1b and related drugs in multiple sclerosis: comparative meta-analysis]. Neurologia i neurochirurgia polska, 2001, Volume: 35, Issue:4 Suppl Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Azathioprine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methylprednisolone; Multiple Sclerosis	2001
[Corticosteroids in the treatment of multiple sclerosis and optic neuritis]. Duodecim; laaketieteellinen aikakauskirja, 2000, Volume: 116, Issue:15 Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome	2000
Multiple sclerosis: common management issues. Australian family physician, 1992, Volume: 21, Issue:10 Topics: Brain; Combined Modality Therapy; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Palliative Care; Patient Care Team; Prednisolone	1992
The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis. Journal of neuroimmunology, 1992, Volume: 40, Issue:2-3 Topics: Gadolinium; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis	1992
Intrathecal Depo-Medrol: a literature review. The Clinical journal of pain, 1992, Volume: 8, Issue:1 Topics: Animals; Arachnoiditis; Back Pain; Humans; Injections, Spinal; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis	1992
[Steroid therapy in multiple sclerosis]. Schweizerische medizinische Wochenschrift, 1991, Jun-29, Volume: 121, Issue:26 Topics: Adrenocorticotropic Hormone; Autoimmunity; Blood-Brain Barrier; Clinical Trials as Topic; Humans; Methylprednisolone; Multiple Sclerosis; Steroids	1991
[Immunosuppressive treatment of multiple sclerosis (review of the literature]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1990, Volume: 90, Issue:2 Topics: Adrenocorticotropic Hormone; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Glucocorticoids; Humans; Immunization, Passive; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis; Plasmapheresis; Prednisolone	1990
Effects of high-to-mega-dose synthetic corticosteroids on multiple sclerosis patients with special reference to cerebrospinal fluid antibodies to myelin basic protein. Clinical neuropharmacology, 1987, Volume: 10, Issue:5 Topics: Antibodies; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Myelin Basic Protein; Prednisone	1987
Immunosuppressive treatment of multiple sclerosis. Mayo Clinic proceedings, 1989, Volume: 64, Issue:6 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferons; Methylprednisolone; Multiple Sclerosis	1989
[Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years]. Revue neurologique, 1989, Volume: 145, Issue:5 Topics: Analysis of Variance; Clinical Protocols; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Longitudinal Studies; Male; Methylprednisolone; Multiple Sclerosis; Plasmapheresis	1989
[Treatment of patients in an acute stage of multiple sclerosis using high-dose methylprednisolone]. Nederlands tijdschrift voor geneeskunde, 1988, Nov-19, Volume: 132, Issue:47 Topics: Acute Disease; Adrenocorticotropic Hormone; Humans; Methylprednisolone; Multiple Sclerosis	1988
Dangers from methylprednisolone acetate therapy by intraspinal injection. Archives of neurology, 1988, Volume: 45, Issue:7 Topics: Demyelinating Diseases; Humans; Injections, Epidural; Injections, Spinal; Intervertebral Disc; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis; Nervous System Diseases; Neurology; Polyethylene Glycols; Spinal Diseases; Spinal Nerve Roots	1988

Trials

103 trial(s) available for methylprednisolone and MS (Multiple Sclerosis)

Article	Year
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial. Revue neurologique, 2022, Volume: 178, Issue:3 Topics: Cost-Benefit Analysis; Humans; Methylprednisolone; Multiple Sclerosis; Recurrence	2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapse. Neurologia, 2022, Volume: 37, Issue:7 Topics: Brain; Gadolinium; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Recurrence	2022
Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:1 Topics: 4-Aminopyridine; Double-Blind Method; Humans; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Potassium Channel Blockers; Treatment Outcome	2023
Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial. Multiple sclerosis and related disorders, 2021, Volume: 47 Topics: Activities of Daily Living; Administration, Intravenous; Double-Blind Method; Humans; Methylprednisolone; Multiple Sclerosis; Recurrence	2021
A randomized pilot trial of oral prednisone taper vs placebo following iv methylprednisolone for multiple sclerosis relapses: Effects on adrenal function and clinical efficacy. Multiple sclerosis and related disorders, 2021, Volume: 50 Topics: Humans; Methylprednisolone; Multiple Sclerosis; Pilot Projects; Prednisone; Recurrence; Treatment Outcome	2021
Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies. Multiple sclerosis and related disorders, 2019, Volume: 30 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Histamine Antagonists; Humans; Immunologic Factors; Infusions, Intravenous; Injection Site Reaction; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	2019
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS. Multiple sclerosis (Houndmills, Basingstoke, England), 2014, Volume: 20, Issue:6 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Disability Evaluation; Double-Blind Method; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Treatment Outcome	2014
MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study. Neurology, 2014, Apr-29, Volume: 82, Issue:17 Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Natalizumab; Neuroprotective Agents; Peptides; Quality of Life; Secondary Prevention; Treatment Outcome; Young Adult	2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses. Multiple sclerosis (Houndmills, Basingstoke, England), 2015, Volume: 21, Issue:5 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Cytokines; Disability Evaluation; Double-Blind Method; Female; Humans; Interferon-gamma; Interleukin-6; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Young Adult	2015
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses. Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Outcome Assessment, Health Care; Prognosis; Recurrence; Severity of Illness Index	2016
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin. International journal of molecular sciences, 2016, Sep-30, Volume: 17, Issue:10 Topics: Adolescent; Adult; Disease Progression; Double-Blind Method; Epoetin Alfa; Female; Hematinics; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Optic Neuritis; Placebo Effect; Visual Acuity; Young Adult	2016
The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:7 Topics: Administration, Oral; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; Recurrence; Time Factors; Treatment Outcome; Visual Acuity	2008
Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:7 Topics: Acute Disease; Administration, Oral; Adult; Female; Glucocorticoids; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; Recurrence; Time Factors; Treatment Outcome; Visual Acuity	2008
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:3 Topics: Antibodies; Azathioprine; Drug Resistance; Drug Therapy, Combination; Genes, Reporter; Glucocorticoids; GTP-Binding Proteins; Humans; Immunosuppressive Agents; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Myxovirus Resistance Proteins; RNA, Messenger; Treatment Failure	2009
Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-β. European journal of neurology, 2009, Volume: 16, Issue:1 Topics: Adult; Antibodies, Neutralizing; Clinical Trials as Topic; Dose-Response Relationship, Immunologic; Female; Humans; Interferon-beta; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Treatment Outcome; Young Adult	2009
A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS. Neurology, 2009, Dec-01, Volume: 73, Issue:22 Topics: Administration, Oral; Adult; Brain; Disability Evaluation; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; ROC Curve; Statistics, Nonparametric; Time Factors; Young Adult	2009
Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology, 2010, Volume: 35, Issue:8 Topics: Adrenal Cortex Hormones; Adult; Aged; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Memory; Memory Disorders; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neuroprotective Agents; Psychomotor Performance; Sleep; Sleep Wake Disorders	2010
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology, 2011, Aug-09, Volume: 77, Issue:6 Topics: Adolescent; Adult; Aged; Alemtuzumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Autoantibodies; Autoimmune Diseases; Cohort Studies; Counseling; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prospective Studies; Risk Factors; Smoking; Thyroid Diseases; Treatment Outcome; Young Adult	2011
CNS vasculitis in a patient with MS on daclizumab monotherapy. Neurology, 2013, Jan-29, Volume: 80, Issue:5 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; CD56 Antigen; Cyclophosphamide; Daclizumab; Disability Evaluation; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Killer Cells, Natural; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Vasculitis, Central Nervous System	2013
Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2003, Volume: 9, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Blood-Brain Barrier; Female; Gadolinium; Humans; Immunoglobulin A; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Predictive Value of Tests; Treatment Outcome	2003
A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:9 Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Interprofessional Relations; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Patient Care Team; Physical Therapy Modalities; Recurrence; Treatment Outcome	2003
Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis. Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Antigens, Surface; Cerebrospinal Fluid; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Immunoglobulin G; Injections, Intravenous; Integrin beta1; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Reaction Time; Receptors, Chemokine; Receptors, CXCR3; Serum Albumin; Serum Albumin, Human; T-Lymphocytes; Th1 Cells	2003
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone. Journal of neuroimmunology, 2004, Volume: 146, Issue:1-2 Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Humans; Male; Matrix Metalloproteinase 9; Methylprednisolone; Middle Aged; Multiple Sclerosis; Statistics, Nonparametric	2004
Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS. Journal of the neurological sciences, 2004, Aug-15, Volume: 223, Issue:1 Topics: Adult; Brain; Cyclophosphamide; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gadolinium; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Salvage Therapy; Single-Blind Method; Treatment Outcome	2004
Experience of the optic neuritis treatment trial. Current neurology and neuroscience reports, 2004, Volume: 4, Issue:5 Topics: Adolescent; Adult; Follow-Up Studies; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Placebos; Prednisone; Prognosis; Visual Acuity	2004
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology, 2004, Sep-28, Volume: 63, Issue:6 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Area Under Curve; Biological Availability; Biotransformation; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Liver; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Prednisolone; Prednisone	2004
Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:10 Topics: Absorptiometry, Photon; Adult; Bone Resorption; Female; Femur; Glucocorticoids; Humans; Injections, Intravenous; Lumbar Vertebrae; Male; Methylprednisolone; Multiple Sclerosis	2004
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications. Multiple sclerosis (Houndmills, Basingstoke, England), 2005, Volume: 11, Issue:2 Topics: Adult; Atrophy; Brain; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Prospective Studies	2005
Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. Neurology, 2005, Jun-14, Volume: 64, Issue:11 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hippocampus; Humans; Male; Memory Disorders; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prospective Studies	2005
Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis. European neurology, 2005, Volume: 54, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis	2005
Nasal nitric oxide, the guardian of paranasal sinuses, is paradoxically increased by high doses of intravenous glucocorticoids. Allergy, 2005, Volume: 60, Issue:10 Topics: Adult; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis; Nasal Mucosa; Nitric Oxide	2005
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2005, Volume: 11, Issue:5 Topics: Acute Disease; Anti-Inflammatory Agents; Axons; Biomarkers; Disability Evaluation; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neurofilament Proteins; Optic Neuritis; Predictive Value of Tests; Treatment Outcome	2005
Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation. Acta neurologica Scandinavica, 2006, Volume: 113, Issue:3 Topics: Adult; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Central Nervous System; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Receptors, CCR5	2006
The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Evoked Potentials, Visual; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Ultrasonography, Doppler, Transcranial	2006
High dose of intravenously given glucocorticosteroids decrease IL-8 production by monocytes in multiple sclerosis patients treated during relapse. Journal of neuroimmunology, 2006, Volume: 176, Issue:1-2 Topics: Adult; Female; Humans; Injections, Intravenous; Interleukin-6; Interleukin-8; Killer Cells, Natural; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis	2006
Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosis. European journal of neurology, 2006, Volume: 13, Issue:8 Topics: Adult; Body Mass Index; Cholesterol; Cohort Studies; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Osteonecrosis; Treatment Outcome	2006
[Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data]. Neurologia (Barcelona, Spain), 2008, Volume: 23, Issue:2 Topics: Adult; Disability Evaluation; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis; Prospective Studies; Recurrence; Severity of Illness Index; Treatment Outcome	2008
[Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study]. Revue neurologique, 2008, Volume: 164, Issue:1 Topics: Adult; Analgesics; Anti-Inflammatory Agents; Cognition Disorders; Depression; Disease Progression; Female; Humans; Male; Memory; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Neuropsychological Tests; Psychomotor Performance	2008
"Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis. Italian journal of neurological sciences, 1983, Volume: 4, Issue:2 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pharmaceutical Vehicles; Random Allocation	1983
Therapeutic trials in multiple sclerosis: azathioprine. Annals of the New York Academy of Sciences, 1984, Volume: 436 Topics: Adult; Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Time Factors	1984
[Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase]. Rinsho shinkeigaku = Clinical neurology, 1995, Volume: 35, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases	1995
Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis. European neurology, 1995, Volume: 35, Issue:4 Topics: Adult; Chronic Disease; Cross-Over Studies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Placebos	1995
Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment. Italian journal of neurological sciences, 1994, Volume: 15, Issue:7 Topics: Adult; Dexamethasone; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis	1994
[Corticosteroids and acute optic nerve neuritis. A therapeutic method requiring further studies]. Lakartidningen, 1995, Feb-01, Volume: 92, Issue:5 Topics: Acute Disease; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Risk Factors	1995
The optic neuritis treatment trial: three-year follow-up results. Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:2 Topics: Drug Therapy, Combination; Follow-Up Studies; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisolone; Randomized Controlled Trials as Topic	1995
Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. European neurology, 1994, Volume: 34, Issue:4 Topics: Adult; CD4-Positive T-Lymphocytes; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Immunoglobulin G; Leukocyte Count; Long-Term Care; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Recurrence	1994
High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:7 Topics: Administration, Oral; Adult; Aged; Bone and Bones; Calcitriol; Calcium; Female; Glomerular Filtration Rate; Humans; Injections, Intravenous; Kidney; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Osteocalcin; Parathyroid Hormone; Phosphorus; Prednisone	1994
Steroids in multiple sclerosis. Journal of clinical pharmacy and therapeutics, 1994, Volume: 19, Issue:4 Topics: Cost-Benefit Analysis; Drug Administration Schedule; Drug Delivery Systems; Drug Evaluation; Humans; Methylprednisolone; Multiple Sclerosis; Recurrence	1994
[Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)]. Klinische Monatsblatter fur Augenheilkunde, 1994, Volume: 205, Issue:3 Topics: Administration, Oral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisolone; Visual Acuity	1994
[Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk]. Deutsche medizinische Wochenschrift (1946), 1994, Jun-17, Volume: 119, Issue:24 Topics: Acute Disease; Administration, Oral; Adult; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisone; Prospective Studies; Risk Factors	1994
Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose. Journal of neurology, neurosurgery, and psychiatry, 1993, Volume: 56, Issue:11 Topics: Administration, Oral; Adult; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Placebos	1993
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. The New England journal of medicine, 1993, Dec-09, Volume: 329, Issue:24 Topics: Acute Disease; Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; Proportional Hazards Models; Recurrence; Risk; Treatment Outcome	1993
The Optic Neuritis Treatment Trial. Putting the results in perspective. The Optic Neuritis Study Group. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1995, Volume: 15, Issue:3 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisone; Prospective Studies; Treatment Outcome	1995
Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study. Neurology, 1996, Volume: 46, Issue:6 Topics: Adult; Autoimmune Diseases; Azathioprine; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pilot Projects; Plasma Exchange; Severity of Illness Index; Single-Blind Method; Treatment Outcome	1996
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology, 1996, Volume: 46, Issue:6 Topics: Acute Disease; Anti-Inflammatory Agents; Autoimmune Diseases; Blood-Brain Barrier; Cerebrospinal Fluid Proteins; Collagenases; Gelatinases; Glycoproteins; Humans; Magnetic Resonance Imaging; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Methylprednisolone; Multiple Sclerosis; Tissue Inhibitor of Metalloproteinases; Urokinase-Type Plasminogen Activator	1996
Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test. Journal of endocrinological investigation, 1996, Volume: 19, Issue:1 Topics: Adrenocorticotropic Hormone; Adult; Female; Glucocorticoids; Glucose Tolerance Test; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Recurrence; Steroids	1996
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:2 Topics: Adjuvants, Immunologic; Adult; Alopecia; Amenorrhea; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukopenia; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis	1997
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (London, England), 1997, Mar-29, Volume: 349, Issue:9056 Topics: Administration, Oral; Adult; Disability Evaluation; Double-Blind Method; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Time Factors; Treatment Outcome	1997
Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis. Journal of neuroimmunology, 1997, Volume: 74, Issue:1-2 Topics: Administration, Oral; Cell Adhesion Molecules; Cell Membrane; Double-Blind Method; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Osmolar Concentration; T-Lymphocyte Subsets; T-Lymphocytes; Tissue Distribution; Tumor Necrosis Factor-alpha	1997
The effects of high-dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis. Journal of the neurological sciences, 1997, Nov-25, Volume: 152, Issue:2 Topics: Acoustic Stimulation; Adult; Artifacts; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Humans; Infusions, Intravenous; Methylprednisolone; Middle Aged; Multiple Sclerosis; Placebos; Reproducibility of Results	1997
Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS. Neurology, 1998, Volume: 50, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Cell Adhesion; Cell Adhesion Molecules; E-Selectin; Female; Humans; Injections, Intravenous; Intercellular Adhesion Molecule-1; L-Selectin; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis; Solubility; Vascular Cell Adhesion Molecule-1	1998
Changes in nitrite and nitrate (NO2-/NO3-) levels in cerebrospinal fluid of patients with multiple sclerosis. Journal of the neurological sciences, 1997, Dec-09, Volume: 153, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Nitrates; Nitric Acid	1997
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis. Neurology, 1998, Volume: 50, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Brain; Gadolinium DTPA; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Recombinant Proteins; Recurrence; Time Factors	1998
T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone marrow transplantation, 1998, Volume: 21, Issue:6 Topics: Adult; Antigens, CD34; Combined Modality Therapy; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation	1998
Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study. Neurology, 1998, Volume: 50, Issue:6 Topics: Adult; Brain; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neck; Neuroprotective Agents; Recurrence; Spinal Cord	1998
Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients. Acta neurologica Scandinavica, 1998, Volume: 97, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Binding Sites; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulins; Lymphocytes; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1998
Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. Acta neurologica Scandinavica, 1998, Volume: 97, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Injections, Intravenous; Male; Memory Disorders; Methylprednisolone; Multiple Sclerosis; Neuropsychological Tests; Recurrence; Remission Induction; Severity of Illness Index	1998
A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis. Neurology, 1998, Volume: 51, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Survival Analysis; Treatment Failure	1998
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS. Neurology, 1998, Volume: 51, Issue:2 Topics: Administration, Oral; Adult; Cost Control; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Surveys and Questionnaires; Treatment Outcome	1998
Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 1998, Volume: 4, Issue:3 Topics: Epitopes; Humans; Methylprednisolone; Monitoring, Physiologic; Multiple Sclerosis; Myelin Basic Protein; Neuroprotective Agents; Recurrence; Remission Induction	1998
Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood, 1998, Nov-15, Volume: 92, Issue:10 Topics: Activities of Daily Living; Adult; Antigens, CD34; Antilymphocyte Serum; Arthritis, Rheumatoid; Autoimmune Diseases; Combined Modality Therapy; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immune Tolerance; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Multiple Sclerosis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation	1998
Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS. Neurology, 1998, Volume: 51, Issue:6 Topics: Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Cell Adhesion Molecules; Female; Humans; Integrin alpha4beta1; Integrins; Intercellular Adhesion Molecule-1; Lymphocyte Function-Associated Antigen-1; Lymphocytes; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis; Receptors, Lymphocyte Homing	1998
Causal inference in a clinical trial: a comparative example. Controlled clinical trials, 1999, Volume: 20, Issue:4 Topics: Azathioprine; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methylprednisolone; Models, Statistical; Multiple Sclerosis; Patient Dropouts; Treatment Refusal	1999
[The comparison of the effectiveness of treatment of multiple sclerosis relapse with high doses of methylprednisolone, alpha-24 corticotropin and cyclophosphamide]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1999, Volume: 6, Issue:36 Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Cosyntropin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Methylprednisolone; Middle Aged; Multiple Sclerosis; Secondary Prevention; Treatment Outcome	1999
[Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis]. Ugeskrift for laeger, 1999, Nov-29, Volume: 161, Issue:48 Topics: Adult; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis; Pain Measurement; Surveys and Questionnaires; Treatment Outcome	1999
Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis. Clinical & experimental ophthalmology, 2000, Volume: 28, Issue:2 Topics: Adult; Female; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Safety; Uveitis, Anterior; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity	2000
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. Journal of neuroimmunology, 2001, Apr-02, Volume: 115, Issue:1-2 Topics: Acute Disease; Adjuvants, Immunologic; Adult; Aged; Anti-Inflammatory Agents; Chemokine CCL2; Chemokine CXCL10; Chemokines, CXC; Female; Humans; Interferon beta-1a; Interferon-beta; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Severity of Illness Index; Treatment Outcome	2001
Clinico-laboratory study of methylprednisolone and cyclophosphamide treatment in patients with multiple sclerosis relapse. Folia medica, 2000, Volume: 42, Issue:3 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Treatment Outcome	2000
[Therapeutic efficacy during active phases of multiple sclerosis: gait analysis and comparison with the EDSS score]. Revue neurologique, 2001, Volume: 157, Issue:6-7 Topics: Adult; Female; Gait; Humans; Locomotion; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Prospective Studies; Single-Blind Method; Treatment Outcome	2001
Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells. Journal of neuroimmunology, 2001, Aug-30, Volume: 118, Issue:2 Topics: Adult; Antibodies, Monoclonal; Cell Count; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Interferon-gamma; Interleukin-4; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Predictive Value of Tests; Th1 Cells; Th2 Cells	2001
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. European journal of neurology, 2001, Volume: 8, Issue:6 Topics: Anti-Inflammatory Agents; Chemokine CCL2; Chemokine CXCL10; Chemokines, CXC; Humans; Immunoglobulin G; Immunoglobulin M; Magnetic Resonance Imaging; Matrix Metalloproteinase 9; Methylprednisolone; Multiple Sclerosis; Neopterin	2001
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. Acta neurologica Belgica, 2001, Volume: 101, Issue:4 Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting	2001
Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects. Clinical and experimental immunology, 2002, Volume: 127, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Antigens, CD; Female; Humans; Immunophenotyping; Lymphocyte Subsets; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR3; Recurrence; Time Factors	2002
A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta neurologica Scandinavica, 2002, Volume: 105, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Evoked Potentials, Motor; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neural Conduction; Neuroprotective Agents; Recurrence; Transcranial Magnetic Stimulation; Treatment Outcome	2002
Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta neurologica Scandinavica, 2002, Volume: 105, Issue:3 Topics: Administration, Oral; Adult; Cognition; Disabled Persons; Endpoint Determination; Female; Health Status; Humans; Infusions, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Recurrence; Sensitivity and Specificity; Surveys and Questionnaires; Treatment Outcome	2002
Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis. Journal of neuroimmunology, 2002, Volume: 125, Issue:1-2 Topics: Adult; Female; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nitric Oxide; Optic Neuritis; Predictive Value of Tests; Receptors, CCR5	2002
[Our experiences in the treatment of multiple sclerosis by intrathecal administration of methylprednisolone acetate and follow-up of the cerebrospinal fluid changes during this treatment]. Ceskoslovenska neurologie a neurochirurgie, 1975, Volume: 38, Issue:6 Topics: Adult; Clinical Trials as Topic; Female; Humans; Injections, Spinal; Methylprednisolone; Middle Aged; Multiple Sclerosis	1975
Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study. Journal of neurology, 1992, Volume: 239, Issue:1 Topics: Adrenal Cortex Hormones; Female; Headache; Humans; Injections, Intravenous; Injections, Spinal; Male; Methylprednisolone; Multiple Sclerosis; Severity of Illness Index; Triamcinolone Acetonide	1992
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. The New England journal of medicine, 1992, Feb-27, Volume: 326, Issue:9 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Color Perception; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Patient Compliance; Prednisone; Recurrence; Visual Acuity; Visual Fields	1992
Immunosuppressive treatment of multiple sclerosis. Mayo Clinic proceedings, 1989, Volume: 64, Issue:6 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferons; Methylprednisolone; Multiple Sclerosis	1989
Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results. European neurology, 1989, Volume: 29, Issue:1 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Evoked Potentials, Auditory; Evoked Potentials, Visual; Humans; Methylprednisolone; Multiple Sclerosis; Random Allocation	1989
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology, 1989, Volume: 39, Issue:7 Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Recurrence	1989
A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis. Neurology, 1989, Volume: 39, Issue:8 Topics: Adolescent; Adult; Azathioprine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Random Allocation; Time Factors	1989
[Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1989, Dec-01, Volume: 41, Issue:23 Topics: Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunoglobulin G; Methylprednisolone; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Poland; Prednisone	1989
Patient teaching manuals improve retention of treatment information--a controlled clinical trial in multiple sclerosis. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1986, Volume: 18, Issue:1 Topics: Adult; Clinical Trials as Topic; Female; Humans; Male; Manuals as Topic; Memory; Methylprednisolone; Middle Aged; Multiple Sclerosis; Patient Compliance; Patient Education as Topic; Retention, Psychology; Teaching Materials	1986
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:5 Topics: Adolescent; Adult; Clinical Trials as Topic; Complement C9; Dose-Response Relationship, Drug; Double-Blind Method; Evoked Potentials, Visual; Female; Humans; Immunoglobulin G; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Reaction Time; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory	1987
Intravenous methylprednisolone for multiple sclerosis in relapse. Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:2 Topics: Adrenocorticotropic Hormone; Adult; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Random Allocation; Recurrence; Time Factors	1985
Methylprednisolone in multiple sclerosis: a comparative dose study. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:8 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Random Allocation	1988
A double-blind controlled trial of high dose methyl prednisolone in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:2 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Methylprednisolone; Multiple Sclerosis	1988
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:4 Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Methylprednisolone; Multiple Sclerosis	1988
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:5 Topics: Adolescent; Adult; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Evoked Potentials, Visual; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Random Allocation	1987
Evoked potentials predict the clinical changes in a multiple sclerosis drug study. Neurology, 1987, Volume: 37, Issue:11 Topics: Adult; Aged; Azathioprine; Brain Stem; Clinical Trials as Topic; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Random Allocation	1987
High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology, 1986, Volume: 36, Issue:2 Topics: Adult; Aged; Albumins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Immunoglobulin G; Infusions, Parenteral; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisone; Random Allocation; Serum Albumin; Time Factors	1986

Other Studies

358 other study(ies) available for methylprednisolone and MS (Multiple Sclerosis)

Article	Year
Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response. Scientific reports, 2021, 09-30, Volume: 11, Issue:1 Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents; Calcitriol; Disability Evaluation; Female; Gene Expression; Humans; Hydrocortisone; Leucine Zippers; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Recurrence	2021
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre study. Multiple sclerosis and related disorders, 2022, Volume: 63 Topics: Adrenal Cortex Hormones; Alemtuzumab; Blood Pressure; Humans; Methylprednisolone; Multiple Sclerosis; Premedication; Recurrence; Retrospective Studies	2022
Efficacy of different intensity of aquatic exercise in enhancing remyelination and neuronal plasticity using cuprizone model in male Wistar rats. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2022, Volume: 31, Issue:9 Topics: Animals; Brain-Derived Neurotrophic Factor; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Basic Protein; Neuronal Plasticity; Neuroprotective Agents; Rats; Rats, Wistar; Remyelination	2022
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis. Multiple sclerosis and related disorders, 2022, Volume: 63 Topics: Bayes Theorem; COVID-19; Humans; Male; Methylprednisolone; Multiple Sclerosis; Personal Protective Equipment	2022
Evaluation of liver injury in multiple sclerosis patients receiving pulsed steroid therapy. Multiple sclerosis and related disorders, 2022, Volume: 65 Topics: Alcoholism; Humans; Methylprednisolone; Multiple Sclerosis; Non-alcoholic Fatty Liver Disease	2022
Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen. Multiple sclerosis and related disorders, 2022, Volume: 66 Topics: Alemtuzumab; Canada; Cytokines; Histamine H2 Antagonists; Humans; Methylprednisolone; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Prednisone; Recurrence	2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses. Journal of neuroinflammation, 2022, Sep-07, Volume: 19, Issue:1 Topics: Humans; Methylprednisolone; Multiple Sclerosis; Prospective Studies; Proteomics; Quality of Life; Recurrence	2022
Treatment With Erythropoietin for Patients With Optic Neuritis: Long-term Follow-up. Neurology(R) neuroimmunology & neuroinflammation, 2023, Volume: 10, Issue:4 Topics: Erythropoietin; Follow-Up Studies; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Quality of Life; Visual Acuity	2023
Clinical findings and outcomes of uveitis associated with multiple sclerosis. European journal of ophthalmology, 2021, Volume: 31, Issue:2 Topics: Adolescent; Adult; Child; Female; Fluorescein Angiography; Glucocorticoids; Humans; Macular Edema; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence; Uveitis; Visual Acuity; Young Adult	2021
Progressive Multifocal Leukoencephalopathy associated to treatment with natalizumab in Mexican patient Multiple Sclerosis. Case report, analysis and update. Neuro endocrinology letters, 2019, Volume: 40, Issue:5 Topics: Female; Humans; Immunoglobulins; Leukoencephalopathy, Progressive Multifocal; Methylprednisolone; Mexico; Middle Aged; Mirtazapine; Multiple Sclerosis; Natalizumab; Plasmapheresis	2019
Hindsight is 20/20. Journal of hospital medicine, 2020, 04-01, Volume: 15, Issue:4 Topics: Abdominal Pain; Adult; Female; Humans; Hypesthesia; Immunologic Factors; Methylprednisolone; Multiple Sclerosis; Natalizumab; Neuroprotective Agents	2020
Methylprednisolone induced liver injury in a patient with multiple sclerosis. Journal of gastrointestinal and liver diseases : JGLD, 2020, 03-13, Volume: 29, Issue:1 Topics: Administration, Intravenous; Adult; Biopsy; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Liver; Liver Function Tests; Methylprednisolone; Multiple Sclerosis; Remission Induction; Withholding Treatment	2020
Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis. Multiple sclerosis and related disorders, 2020, Volume: 42 Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Hepatitis; Hepatitis, Autoimmune; Humans; Immunologic Factors; Methylprednisolone; Middle Aged; Multiple Sclerosis	2020
Transient myocardial ischemia due to corticosteroid use in a patient with multiple sclerosis diagnosed with myocardial perfusion imaging. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:4 Topics: Coronary Angiography; Female; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myocardial Ischemia; Myocardial Perfusion Imaging	2021
Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules. Multiple sclerosis and related disorders, 2020, Volume: 44 Topics: Adult; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Retrospective Studies	2020
Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone. Clinical neurology and neurosurgery, 2020, Volume: 197 Topics: Adult; Breast Feeding; Female; Glucocorticoids; Humans; Infusions, Intravenous; Lactation; Methylprednisolone; Milk, Human; Multiple Sclerosis; Young Adult	2020
Internuclear Ophthalmoplegia as the First Manifestation of Pediatric-Onset Multiple Sclerosis and Concurrent Lyme Disease. The American journal of case reports, 2020, Oct-07, Volume: 21 Topics: Adolescent; Child; Female; Humans; Lyme Disease; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Ocular Motility Disorders	2020
Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor β and S100A8/9 up-regulation. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:23 Topics: Animals; Arginase; Biomarkers; Calgranulin A; Calgranulin B; Disease Models, Animal; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Humans; Immunophenotyping; Leukocytes, Mononuclear; Methylprednisolone; Mice; Multiple Sclerosis; Myeloid-Derived Suppressor Cells; Receptors, Glucocorticoid; T-Lymphocytes	2020
Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis. Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:2 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; JC Virus; Leukapheresis; Leukoencephalopathy, Progressive Multifocal; Methylprednisolone; Middle Aged; Multiple Sclerosis; Remission Induction; Sphingosine-1-Phosphate Receptors; Tumor Necrosis Factor-alpha; Virus Activation	2021
Phelan McDermid Syndrome: Multiple Sclerosis as a Rare but Treatable Cause for Regression-A Case Report. International journal of molecular sciences, 2021, Feb-25, Volume: 22, Issue:5 Topics: Abnormalities, Multiple; Administration, Intravenous; Adult; Autism Spectrum Disorder; Autoimmune Diseases; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, 21-22 and Y; Chromosomes, Human, Pair 22; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Nerve Tissue Proteins; Regression, Psychology; Sequence Deletion; Spinal Puncture	2021
A Case of Combined Central and Peripheral Demyelination Associated With Antineurofascin 155 Antibodies and Paternal History of Multiple Sclerosis. The neurologist, 2021, Jul-06, Volume: 26, Issue:4 Topics: Adult; Demyelinating Diseases; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Rituximab	2021
Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting. Multiple sclerosis and related disorders, 2021, Volume: 54 Topics: Administration, Oral; COVID-19; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Pandemics; Powders; Recurrence; Retrospective Studies; SARS-CoV-2; Water	2021
Fulminant tumefactive multiple sclerosis in pregnancy. BMJ case reports, 2017, Jun-13, Volume: 2017 Topics: Adult; Diagnosis, Differential; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Plasma Exchange; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Prenatal Diagnosis	2017
Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2018, Volume: 24, Issue:9 Topics: Adult; Anti-Inflammatory Agents; Breast Feeding; Female; Humans; Infant; Male; Methylprednisolone; Milk, Human; Multiple Sclerosis; Postpartum Period; Pregnancy	2018
Outcome of MS relapses in the era of disease-modifying therapy. BMC neurology, 2017, Aug-07, Volume: 17, Issue:1 Topics: Adult; Disease Progression; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Multiple Sclerosis; Plasmapheresis; Prospective Studies; Recurrence; Treatment Outcome	2017
Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis. Steroids, 2017, Volume: 128 Topics: Adrenal Cortex Hormones; Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Interferon-gamma; Interleukin-4; Melatonin; Methylprednisolone; Multiple Sclerosis; Rats; Th1 Cells; Th2 Cells	2017
Effective combination of methylprednisolone and interferon β-secreting mesenchymal stem cells in a model of multiple sclerosis. Journal of neuroimmunology, 2018, 01-15, Volume: 314 Topics: Animals; Anti-Inflammatory Agents; Encephalomyelitis, Autoimmune, Experimental; Female; Genetic Therapy; Humans; Interferon-beta; Mesenchymal Stem Cell Transplantation; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Spinal Cord	2018
Effects of multiple sclerosis and medications on menopausal age. The Journal of international medical research, 2018, Volume: 46, Issue:3 Topics: Adult; Age Factors; Case-Control Studies; Disability Evaluation; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Menopause; Methylprednisolone; Middle Aged; Multiple Sclerosis	2018
Clinical commentary on "Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica". Multiple sclerosis (Houndmills, Basingstoke, England), 2018, Volume: 24, Issue:11 Topics: Anaphylaxis; Aquaporin 4; Humans; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica	2018
Management of optic neuritis in Ireland: a survey comparing the management practices of acute demyelinating optic neuritis amongst ophthalmologists and neurologists in Ireland. Irish journal of medical science, 2019, Volume: 188, Issue:1 Topics: Acute Disease; Clinical Laboratory Techniques; Demyelinating Diseases; Female; Glucocorticoids; Health Care Surveys; Humans; Ireland; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neurologists; Ophthalmologists; Optic Neuritis; Practice Patterns, Physicians'	2019
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients. Brain and behavior, 2018, Volume: 8, Issue:6 Topics: Adult; Chemical and Drug Induced Liver Injury; Drug Monitoring; Female; Glucocorticoids; Humans; Italy; Liver Function Tests; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prevalence; Prospective Studies; Pulse Therapy, Drug; Secondary Prevention; Severity of Illness Index	2018
Toxic liver injury after high-dose methylprednisolone in people with multiple sclerosis. Multiple sclerosis and related disorders, 2018, Volume: 25 Topics: Adult; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Methylprednisolone; Middle Aged; Multiple Sclerosis	2018
Microglia polarization by methylprednizolone acetate accelerates cuprizone induced demyelination. Journal of molecular histology, 2018, Volume: 49, Issue:5 Topics: Animals; Chemokine CXCL10; Cuprizone; Demyelinating Diseases; Inflammation; Methylprednisolone; Mice; Microglia; Multiple Sclerosis	2018
Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. Multiple sclerosis and related disorders, 2018, Volume: 25 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Indonesia; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Statistics, Nonparametric; Vitamin D; Vitamin D Deficiency; Young Adult	2018
Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol. Multiple sclerosis and related disorders, 2019, Volume: 27 Topics: Acetaminophen; Administration, Intravenous; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Body Mass Index; Cetirizine; Diphenhydramine; Female; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Premedication; Ranitidine; Sex Factors; Treatment Outcome; Young Adult	2019
Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis. BMJ case reports, 2018, Dec-07, Volume: 11, Issue:1 Topics: Adolescent; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Glucocorticoids; Humans; Methylprednisolone; Multiple Sclerosis; Pulse Therapy, Drug	2018
Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment. Clinics and research in hepatology and gastroenterology, 2019, Volume: 43, Issue:3 Topics: Adult; Autoantibodies; Azathioprine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Liver Function Tests; Male; Methylprednisolone; Multiple Sclerosis; Mycophenolic Acid; Prednisolone	2019
MULTIPLE SCLEROSIS OR FABRY DISEASE - PROS AND CONS. Acta clinica Croatica, 2018, Volume: 57, Issue:4 Topics: Adult; Brain; Diagnosis, Differential; Enzyme Replacement Therapy; Fabry Disease; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Optic Neuritis; Pedigree; Treatment Outcome; Vision Disorders	2018
Whole-body reversible neuropathic pain associated with right parieto-temporal operculum single inflammatory lesion in a patient with multiple sclerosis: A case report. European journal of pain (London, England), 2019, Volume: 23, Issue:10 Topics: Adult; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuralgia; Parietal Lobe; Temporal Lobe; White Matter	2019
Natalizumab therapy for highly active pediatric multiple sclerosis. JAMA neurology, 2013, Volume: 70, Issue:4 Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Austria; Disability Evaluation; Female; Follow-Up Studies; Germany; Humans; Immunologic Factors; Integrin alpha4; Interferon-beta; Leukocyte Count; Liver; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Natalizumab; Retrospective Studies; Secondary Prevention	2013
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. Swiss medical weekly, 2013, Volume: 143 Topics: Actigraphy; Adolescent; Adult; Aged; Demyelinating Autoimmune Diseases, CNS; Depression; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Sleep Initiation and Maintenance Disorders; Young Adult	2013
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment. Journal of neurology, 2013, Volume: 260, Issue:9 Topics: Administration, Intravenous; Adult; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Female; Glucocorticoids; Hemodynamics; Homeostasis; Humans; Male; Methylprednisolone; Middle Cerebral Artery; Multiple Sclerosis; Tilt-Table Test; Ultrasonography, Doppler, Transcranial	2013
A teenage girl with new-onset diplopia and sharp, shooting leg pain. Pediatric annals, 2013, Volume: 42, Issue:8 Topics: Adolescent; Brain; Diagnosis, Differential; Diplopia; Female; Glucocorticoids; Humans; Infusions, Intravenous; Leg; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Pain	2013
Susac's syndrome: an immune mediated endotheliopathy laden with challenges and controversies. BMJ case reports, 2013, Aug-19, Volume: 2013 Topics: Adult; Audiometry, Pure-Tone; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Leukoencephalopathies; Methylprednisolone; Multiple Sclerosis; Susac Syndrome	2013
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis. Chinese medical journal, 2013, Volume: 126, Issue:18 Topics: Animals; Drug Combinations; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Methylprednisolone; Mice; Mice, Inbred C57BL; Multiple Sclerosis	2013
Evaluation of clinical parameters during and after treatment of attack in patients with clinically isolated syndrome: comparison of the results with that of multiple sclerosis patients. Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:12 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Disability Evaluation; Fatigue; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Neuropsychological Tests; Prognosis; Young Adult	2013
Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern. Journal of molecular neuroscience : MN, 2014, Volume: 53, Issue:3 Topics: Adult; Case-Control Studies; Chemokine CCL20; Female; Humans; Interferon-beta; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Polymorphism, Single Nucleotide; Sex Factors	2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8 Topics: Adult; Age of Onset; Anti-Inflammatory Agents; Databases, Factual; Disability Evaluation; Female; Follow-Up Studies; Humans; Interferon-beta; Italy; Methylprednisolone; Multiple Sclerosis; Postpartum Period; Pregnancy; Pregnancy Outcome; Prospective Studies; Recurrence; Risk Assessment; Risk Factors	2014
Dual diagnosis: rheumatoid arthritis and multiple sclerosis. PM & R : the journal of injury, function, and rehabilitation, 2014, Volume: 6, Issue:1 Topics: Adult; Arthritis, Juvenile; Bone and Bones; Brain; Female; Glucocorticoids; Humans; Hypesthesia; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Muscle Weakness; Radiography	2014
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Apolipoproteins; Apolipoproteins E; Atrophy; Brain; Data Interpretation, Statistical; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Lipids; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prospective Studies; Young Adult	2014
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis. The Journal of international medical research, 2014, Volume: 42, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Guinea Pigs; Immunosuppressive Agents; IMP Dehydrogenase; Interleukin-2 Receptor alpha Subunit; Leukocyte Common Antigens; Lymphocyte Count; Methylprednisolone; Multiple Sclerosis; Mycophenolic Acid; Random Allocation; Rats; Rats, Wistar; T-Lymphocyte Subsets	2014
Neuro-Behçet's disease: an unusual cause of headache. Journal of general internal medicine, 2014, Volume: 29, Issue:6 Topics: Anti-Inflammatory Agents; Behcet Syndrome; Diagnosis, Differential; Female; Gait Disorders, Neurologic; Headache; Humans; Ibuprofen; Meningitis, Aseptic; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neoplasms; Neuroimaging; Neurologic Examination; Treatment Outcome	2014
Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question? Multiple sclerosis (Houndmills, Basingstoke, England), 2014, Volume: 20, Issue:6 Topics: Administration, Intravenous; Administration, Oral; Glucocorticoids; Humans; Methylprednisolone; Multiple Sclerosis; Recurrence	2014
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis. Journal of neuroimmunology, 2014, Nov-15, Volume: 276, Issue:1-2 Topics: Adult; Anti-Inflammatory Agents; Female; Flow Cytometry; Humans; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Severity of Illness Index	2014
Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. European neurology, 2014, Volume: 72, Issue:3-4 Topics: Adult; Aged; Analysis of Variance; Antioxidants; Cholesterol; Disability Evaluation; Glutathione; Humans; Lipid Peroxidation; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurodegenerative Diseases; Oxidative Stress; Reactive Oxygen Species	2014
Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program. Journal of molecular neuroscience : MN, 2015, Volume: 55, Issue:4 Topics: Adult; Case-Control Studies; Female; Forkhead Transcription Factors; Humans; Interferon-beta; Interleukins; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Polymorphism, Single Nucleotide	2015
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders. Journal of neuroimmunology, 2015, Jan-15, Volume: 278 Topics: Adult; Aged; Anti-Inflammatory Agents; Case-Control Studies; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Severity of Illness Index; T-Lymphocytes, Helper-Inducer; Young Adult	2015
[Short-term high-dose intravenous methylprednisolone therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2014, Volume: 72, Issue:11 Topics: Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Time Factors	2014
Transfer of methylprednisolone into breast milk in a mother with multiple sclerosis. Journal of human lactation : official journal of International Lactation Consultant Association, 2015, Volume: 31, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Breast Feeding; Female; Humans; Infant, Newborn; Infusions, Intravenous; Methylprednisolone; Milk, Human; Multiple Sclerosis; Pregnancy	2015
[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2015, Volume: 53, Issue:4 Topics: Adolescent; Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Brain; Brain Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies	2015
Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis. BMJ case reports, 2015, Jul-21, Volume: 2015 Topics: Acute Disease; Adult; Biopsy; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Female; Glatiramer Acetate; Hepatitis; Humans; Immunoglobulins; Liver; Liver Function Tests; Methylprednisolone; Multiple Sclerosis	2015
Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption. BMC neurology, 2015, Jul-31, Volume: 15 Topics: Adsorption; Adult; Autoantibodies; Female; Fingolimod Hydrochloride; Humans; Immunoglobulin G; Immunologic Factors; Lymphopenia; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Myelin Sheath; Natalizumab; Plasma Exchange; Steroids; Treatment Outcome	2015
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report. Journal of medical case reports, 2015, Sep-24, Volume: 9 Topics: Bradycardia; Electrocardiography; Female; Glucocorticoids; Humans; Infusions, Intravenous; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pulse Therapy, Drug	2015
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis]. Revista de neurologia, 2015, Oct-01, Volume: 61, Issue:7 Topics: Adult; Brain; Combined Modality Therapy; Deglutition Disorders; Dysarthria; Facial Paralysis; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Natalizumab; Neuroimaging; Optic Neuritis; Plasmapheresis	2015
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:10 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome; Young Adult	2016
[Acute disseminated encephalomyelitis in Tunisia: Report of a pediatric cohort]. Revue neurologique, 2015, Volume: 171, Issue:12 Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents; Basal Ganglia Diseases; Child; Child, Preschool; Cohort Studies; Encephalomyelitis, Acute Disseminated; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Multiple Sclerosis; Oligoclonal Bands; Retrospective Studies; Treatment Outcome; Tunisia	2015
Atypical presentation of multiple sclerosis. Journal francais d'ophtalmologie, 2016, Volume: 39, Issue:1 Topics: Brain Neoplasms; Diagnosis, Differential; Female; Glioma; Hemianopsia; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisolone	2016
Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod. The International journal of neuroscience, 2016, Volume: 126, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Cohort Studies; Disability Evaluation; Female; Fingolimod Hydrochloride; Humans; Immunologic Factors; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Natalizumab; Time Factors	2016
Four hours is enough for lactation interruption after high-dose methylprednisolone treatment in multiple sclerosis mothers by measuring milk cortisol levels. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016, Volume: 29, Issue:21 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Hydrocortisone; Lactation; Methylprednisolone; Milk, Human; Multiple Sclerosis; Time Factors	2016
Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge! Neurology, 2016, Mar-08, Volume: 86, Issue:10 Topics: Adult; Female; Humans; Methylprednisolone; Multiple Sclerosis; Neuroimmunomodulation; Retinal Necrosis Syndrome, Acute	2016
The Impact of Methylprednisolone Pulses during Relapses of Multiple Sclerosis on the Kinetics of Anti-Interferon-Beta Antibodies. European neurology, 2016, Volume: 75, Issue:1-2 Topics: Administration, Intravenous; Adult; Antibodies, Neutralizing; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interferon-beta; Kinetics; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents	2016
Posturography in MS patients treated with high dose methylprednisolone. Neurological research, 2016, Volume: 38, Issue:7 Topics: Adult; Disability Evaluation; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Postural Balance; Posture; Sensation Disorders; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Young Adult	2016
Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®). Advances in therapy, 2016, Volume: 33, Issue:8 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Fees, Pharmaceutical; Female; Health Expenditures; Health Services; Hospitalization; Humans; Immunoglobulin G; Injections, Intravenous; Injections, Subcutaneous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Plasmapheresis; Young Adult	2016
[May neuroimaging findings of a child with multiple sclerosis surprise us? Clinical and radiological observation]. Przeglad lekarski, 2016, Volume: 73, Issue:3 Topics: Brain; Child; Diagnosis, Differential; Dizziness; Evoked Potentials; Headache; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Neuroprotective Agents; Treatment Outcome	2016
Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines. Pharmaceutical development and technology, 2017, Volume: 22, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Brain; Cell Adhesion Molecules; Cell Line, Tumor; Cell Survival; Contactin 2; Disease Models, Animal; Drug Carriers; Endocytosis; Humans; Methylprednisolone; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Electron, Scanning; Multiple Sclerosis; Nanoparticles; Nerve Growth Factors; Surface Properties	2017
Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84 Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Lactic Acid; Methylprednisolone; Multiple Sclerosis; Rats; Rats, Inbred Lew	2016
Etiologic spectrum and functional outcome of the acute inflammatory myelitis. Acta neurologica Belgica, 2017, Volume: 117, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Encephalomyelitis; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica; Recovery of Function; Retrospective Studies; Treatment Outcome; Young Adult	2017
Intravenous methylprednisolone induced acute pancreatitis. European journal of clinical pharmacology, 2017, Volume: 73, Issue:5 Topics: Acute Disease; Administration, Intravenous; Adult; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis; Pancreatitis	2017
Increased intracranial pressure in a case of pediatric multiple sclerosis. Journal of child neurology, 2008, Volume: 23, Issue:6 Topics: Adolescent; Brain; Female; Humans; Immunoglobulin G; Interferon beta-1b; Interferon-beta; Intracranial Hypertension; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Oligoclonal Bands; Prednisone; Spinal Puncture	2008
Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta neurologica Scandinavica, 2009, Volume: 119, Issue:4 Topics: Adult; Aged; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Forkhead Transcription Factors; Gene Expression; Glucocorticoids; Humans; Interleukin-10; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Lymphocyte Count; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Polymerase Chain Reaction; T-Lymphocytes, Regulatory	2009
Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World journal of gastroenterology, 2008, Sep-21, Volume: 14, Issue:35 Topics: Adult; Female; Hepatitis, Autoimmune; Humans; Interferon-gamma; Methylprednisolone; Multiple Sclerosis; Recombinant Proteins	2008
Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2008, Volume: 29, Issue:6 Topics: Activities of Daily Living; Autoimmune Diseases; Autoimmunity; Brain; Cluster Analysis; Connective Tissue Diseases; Disease Progression; Familial Mediterranean Fever; Gait Disorders, Neurologic; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Paraparesis; Spondylitis, Ankylosing; Treatment Failure	2008
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease. Human immunology, 2008, Volume: 69, Issue:12 Topics: Adult; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Celiac Disease; Diet, Gluten-Free; Disease Progression; Female; Headache; Humans; Hypesthesia; Infant, Newborn; Interferon-gamma; Lymphocyte Activation; Male; Methylprednisolone; Monocytes; Multiple Sclerosis; Pregnancy; Pregnancy Complications; Receptors, Fc; Recovery of Function; Remission, Spontaneous; T-Box Domain Proteins; Transcriptional Activation; Transglutaminases	2008
Winning combination: the additive/synergistic benefits of IVIg in corticosteroid refractory optic neuritis. European journal of neurology, 2008, Volume: 15, Issue:11 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Synergism; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Treatment Outcome	2008
Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients. Journal of neurology, 2008, Volume: 255, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Antibodies; Drug Therapy, Combination; Female; Humans; Interferon-beta; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neutralization Tests; Risk Factors; Young Adult	2008
Can we get rid of neutralizing antibodies against interferon-β? European journal of neurology, 2009, Volume: 16, Issue:1 Topics: Antibodies, Neutralizing; Binding Sites, Antibody; Humans; Immunosuppressive Agents; Interferon-beta; Methylprednisolone; Multiple Sclerosis	2009
Paroxysmal hypothermia as a clinical feature of multiple sclerosis. Neurology, 2009, Jan-13, Volume: 72, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Body Temperature Regulation; Disease Progression; Fatal Outcome; Hallucinations; Humans; Hypothalamic Diseases; Hypothalamus; Hypothermia; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Treatment Failure	2009
Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal. Journal of child neurology, 2009, Volume: 24, Issue:4 Topics: Acute Disease; Adolescent; Brain; Cyclophosphamide; Demyelinating Diseases; Facial Nerve Diseases; Frontal Lobe; Hemiplegia; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Nerve Fibers, Myelinated; Ocular Motility Disorders; Paresis; Pons; Recurrence; Treatment Outcome; Vertigo	2009
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Feb-18, Volume: 29, Issue:7 Topics: Animals; Animals, Newborn; Apoptosis; bcl-X Protein; Binding Sites; Cells, Cultured; Cytoprotection; Down-Regulation; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Oligodendroglia; Promoter Regions, Genetic; Rats; Receptors, Glucocorticoid; RNA Interference; Spinal Cord Injuries; STAT5 Transcription Factor; Up-Regulation	2009
Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse. Neurological research, 2010, Volume: 32, Issue:7 Topics: Adolescent; Adult; Chemokine CCL5; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Interleukin-15; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Statistics, Nonparametric; Treatment Outcome	2010
Long-term prognosis of pediatric patients with relapsing acute disseminated encephalomyelitis. Journal of child neurology, 2010, Volume: 25, Issue:6 Topics: Adolescent; Brain; Child; Encephalomyelitis, Acute Disseminated; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Nerve Fibers, Myelinated; Neuroprotective Agents; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome	2010
Effects of methylprednisolone and glatiramer acetate on nitric oxide formation of cytokine-stimulated cells from the rat oligodendroglial cell line OLN-93. Neuroimmunomodulation, 2010, Volume: 17, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Glatiramer Acetate; Immunosuppressive Agents; Interferon-gamma; Methylprednisolone; Multiple Sclerosis; Nerve Fibers, Myelinated; Nitric Oxide; Nitric Oxide Synthase Type II; Oligodendroglia; Peptides; Rats; RNA, Messenger; Stem Cells; Tumor Necrosis Factor-alpha; Up-Regulation	2010
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required. Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Child; Cohort Studies; Female; Humans; Interferon Type I; Leukemia, Myeloid, Acute; Male; Mediterranean Region; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Recombinant Proteins; Risk Assessment; Young Adult	2009
Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination. Transfusion, 2010, Volume: 50, Issue:2 Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Bacteriocins; Blood Group Antigens; Blood Transfusion; Calcium; Cell Membrane Permeability; Cell Shape; Combined Modality Therapy; Cryoglobulins; Erythrocyte Membrane; Glycophorins; Hemolysis; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Models, Immunological; Multiple Sclerosis; Peptides, Cyclic; Phosphatidylethanolamines; Plasmapheresis; Rituximab	2010
One face behind the numbers. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Nov-01, Volume: 66, Issue:21 Topics: Adult; Antiemetics; Clinical Trials as Topic; Diphenhydramine; Female; Glucocorticoids; Humans; Methylprednisolone; Metoclopramide; Multiple Sclerosis; Pharmacists	2009
Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case report. BMC neurology, 2009, Oct-23, Volume: 9 Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Spinal Cord; Treatment Outcome	2009
Micturitional disturbance due to bilateral medial frontal lobe lesions in a patient with multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Nocturnal Enuresis; Time Factors; Treatment Outcome	2010
Bilateral whirlbone necrosis in a young multiple sclerosis patient. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31, Issue:2 Topics: Adult; Betamethasone; Cosyntropin; Femur Head Necrosis; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis	2010
Outcome measurement in multiple sclerosis: detection of clinically relevant improvement. Multiple sclerosis (Houndmills, Basingstoke, England), 2010, Volume: 16, Issue:5 Topics: Adult; Disability Evaluation; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Outcome Assessment, Health Care; Predictive Value of Tests; Psychomotor Performance; Severity of Illness Index; Treatment Outcome	2010
Ring and nodular multiple sclerosis lesions: a retrospective natural history study. Neurology, 2010, Mar-09, Volume: 74, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Contrast Media; Disability Evaluation; Disease Progression; Encephalitis; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Prednisone; Retrospective Studies; Statistics as Topic; Time Factors	2010
Multiple sclerosis exceptionally presenting as parkinsonism responds to intravenous methylprednisolone. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:5 Topics: Disease Progression; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Parkinsonian Disorders; Treatment Outcome	2010
[Pharmacological treatment of multiple sclerosis]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2010, Mar-11, Volume: 130, Issue:5 Topics: Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Glatiramer Acetate; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Natalizumab; Peptides; Secondary Prevention	2010
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:12 Topics: Adult; Female; Glucocorticoids; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Nerve Fibers; Neuromyelitis Optica; Optic Disk; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity	2010
Care at home of the patient with advanced multiple sclerosis: part 1 of 2. Home healthcare nurse, 2010, Volume: 28, Issue:4 Topics: Activities of Daily Living; Glucocorticoids; Home Care Services; Home Care Services, Hospital-Based; Humans; Methylprednisolone; Multiple Sclerosis; Palliative Care; Quality of Life; Secondary Prevention; Severity of Illness Index	2010
Improving combination trials for multiple sclerosis. The Lancet. Neurology, 2010, Volume: 9, Issue:7 Topics: Adjuvants, Immunologic; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Interferon beta-1a; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents	2010
Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy. Folia neuropathologica, 2010, Volume: 48, Issue:2 Topics: Adult; Female; Free Radicals; Glucocorticoids; Humans; Lipid Peroxidation; Male; Methylprednisolone; Multiple Sclerosis; Sulfhydryl Compounds; Superoxide Dismutase; Superoxide Dismutase-1; Thiobarbituric Acid Reactive Substances	2010
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology, 2010, Jul-20, Volume: 75, Issue:3 Topics: Adult; Aged; Antibodies; Aquaporin 4; Astrocytes; Biomarkers; Central Nervous System; Demyelinating Diseases; Disability Evaluation; Encephalomyelitis, Acute Disseminated; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Nerve Growth Factors; Nervous System Diseases; Neurofilament Proteins; Neuromyelitis Optica; Neuroprotective Agents; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Statistics, Nonparametric	2010
[A case of bilateral horizontal gaze ophthalmoplegia: The 1+1 syndrome]. Revue neurologique, 2010, Volume: 166, Issue:12 Topics: Anti-Inflammatory Agents; Brain; Diplopia; Evoked Potentials, Visual; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Ocular Motility Disorders; Pons; Pupil Disorders; Saccades; Visual Acuity; Young Adult	2010
Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC neurology, 2010, Sep-23, Volume: 10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticonvulsants; Epilepsy; Glatiramer Acetate; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Natalizumab; Neuroprotective Agents; Peptides; Young Adult	2010
Fatigue and dizziness during steroid perfusion. Neurology, 2010, Nov-02, Volume: 75, Issue:18 Topics: Adult; Dizziness; Electrocardiography; Fatigue; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis; Perfusion	2010
Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis. Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:11 Topics: Adolescent; Adult; Biomarkers; Cathepsin B; Cathepsins; Cystatin B; Cystatin C; Disease Progression; Female; Humans; Interferon-beta; Leukocytes; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; RNA, Messenger	2011
Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:4 Topics: Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Sweet Syndrome; Treatment Outcome	2011
[Multiple evanescent white dot syndrome and multiple sclerosis]. Journal francais d'ophtalmologie, 2011, Volume: 34, Issue:4 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Brain; Chorioretinitis; Diplopia; Drug Therapy, Combination; Electroretinography; Evoked Potentials, Visual; Female; Fluorescein Angiography; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Papilledema; Prednisone; Tomography, Optical Coherence; Visual Field Tests	2011
The effect of intravenous high-dose methylprednisolone on platelet reactivity assessed with multiple electrode aggregometry. Thrombosis and haemostasis, 2011, Volume: 105, Issue:6 Topics: Adult; Arachidonic Acid; Drug Combinations; Electric Impedance; Electrodes; Female; Hemostasis; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Peptide Fragments; Platelet Aggregation; Statistics, Nonparametric	2011
[Case of multiple sclerosis with "yes-yes" type head tremor]. Rinsho shinkeigaku = Clinical neurology, 2011, Volume: 51, Issue:4 Topics: Adult; Anticonvulsants; Cervical Vertebrae; Clonazepam; Female; Head; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Prednisolone; Pulse Therapy, Drug; Spinal Cord; Treatment Outcome; Tremor	2011
[Multiple sclerosis associated with antiphospholipid syndrome: diagnostic and therapeutic difficulties]. Revue neurologique, 2012, Volume: 168, Issue:1 Topics: Anti-Inflammatory Agents; Antiphospholipid Syndrome; Brachial Plexus Neuritis; Brain; Facial Paralysis; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Paraparesis; Vision Tests	2012
Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis. Journal of the neurological sciences, 2011, Oct-15, Volume: 309, Issue:1-2 Topics: Adolescent; Adult; Arrhythmias, Cardiac; Female; Heart Conduction System; Humans; Incidence; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pulse Therapy, Drug; Smoking; Young Adult	2011
Blurred vision and pain in the eye. The Medical journal of Australia, 2011, Sep-19, Volume: 195, Issue:6 Topics: Acute Disease; Adult; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunologic Factors; Injections, Intravenous; Injections, Subcutaneous; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Pain; Risk Factors; Treatment Outcome; Vision Disorders; Visual Acuity; Visual Fields	2011
Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses. Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:12 Topics: Adolescent; Adult; Demography; Female; Glucocorticoids; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Recurrence; Sample Size; Treatment Outcome; Walking; Young Adult	2011
An autoregressive linear mixed effects model for the analysis of unequally spaced longitudinal data with dose-modification. Statistics in medicine, 2012, Mar-15, Volume: 31, Issue:6 Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Linear Models; Longitudinal Studies; Methylprednisolone; Multiple Sclerosis; Randomized Controlled Trials as Topic	2012
A rare 'palisading' enhancing pattern of multiple sclerosis. European neurology, 2012, Volume: 67, Issue:3 Topics: Adjuvants, Immunologic; Adult; Brain; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Nerve Fibers, Myelinated; Neuroprotective Agents	2012
[Eucharist bacteria brought miserey--bilateral parotitis led to emergency tracheotomy]. Laryngo- rhino- otologie, 2012, Volume: 91, Issue:5 Topics: Acute Disease; Adjuvants, Immunologic; Airway Obstruction; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Emergencies; Female; Humans; Interferon beta-1b; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Opportunistic Infections; Parotitis; Serratia Infections; Serratia marcescens; Tracheotomy; Young Adult	2012
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Cross-Sectional Studies; Female; Health Care Surveys; Humans; Italy; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurology; Recurrence; Surveys and Questionnaires	2013
The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers. Multiple sclerosis (Houndmills, Basingstoke, England), 2012, Volume: 18, Issue:11 Topics: Adult; Case-Control Studies; Chi-Square Distribution; Denmark; Disability Evaluation; Female; Femoral Fractures; Fractures, Bone; Glucocorticoids; Hip Fractures; Humans; Incidence; Logistic Models; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Odds Ratio; Osteoporosis; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Time Factors	2012
Churg-Strauss syndrome in a patient previously diagnosed with multiple sclerosis. BMJ case reports, 2011, Sep-28, Volume: 2011 Topics: Aged; Anti-Inflammatory Agents; Churg-Strauss Syndrome; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis	2011
A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. Journal of the neurological sciences, 2012, Oct-15, Volume: 321, Issue:1-2 Topics: Adult; Anti-Inflammatory Agents; Antigens, Nuclear; Aquaporin 4; Humans; Influenza Vaccines; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Narcolepsy; Spinal Cord	2012
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod. Neurology, 2012, Nov-06, Volume: 79, Issue:19 Topics: Adult; Anti-Inflammatory Agents; Brain; Fingolimod Hydrochloride; Herpes Zoster; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Propylene Glycols; Sphingosine	2012
Cerebral venous thrombosis after lumbar puncture and treatment with high-dose corticosteroids. Neurologia (Barcelona, Spain), 2014, Volume: 29, Issue:5 Topics: Anti-Inflammatory Agents; Cerebral Veins; Humans; Male; Methylprednisolone; Multiple Sclerosis; Spinal Puncture; Venous Thrombosis; Young Adult	2014
Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity. Clinics and research in hepatology and gastroenterology, 2013, Volume: 37, Issue:1 Topics: Adult; Autoimmunity; Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Humans; Methylprednisolone; Multiple Sclerosis	2013
[Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon β-1b therapy]. Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:1 Topics: Adult; Female; Glomerulonephritis, Membranous; Humans; Interferon beta-1b; Interferon-beta; Kidney; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Nephrotic Syndrome; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Time Factors; Treatment Outcome	2013
High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels. Clinical chemistry and laboratory medicine, 2002, Volume: 40, Issue:5 Topics: Adult; Case-Control Studies; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Reagent Kits, Diagnostic; Reference Standards; Time Factors; Uric Acid	2002
De novo aphasic status epilepticus as presenting symptom of multiple sclerosis. Journal of neurology, 2002, Volume: 249, Issue:6 Topics: Adolescent; Aphasia; Apraxias; Carbamazepine; Cerebral Cortex; Diagnosis, Differential; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Nerve Fibers, Myelinated; Status Epilepticus; Treatment Outcome	2002
[Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"]. Der Nervenarzt, 2002, Volume: 73, Issue:12 Topics: Consensus Development Conferences as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Practice Guidelines as Topic; Prednisolone; Pulse Therapy, Drug	2002
Multiple sclerosis with open-ring enhancement in the cerebrum and spinal cord. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:3 Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Plasmapheresis; Spinal Cord; Telencephalon	2003
High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis. European neurology, 2003, Volume: 49, Issue:4 Topics: Anti-Inflammatory Agents; Female; Humans; Infusions, Intravenous; Intracranial Thrombosis; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Risk Factors; Venous Thrombosis	2003
Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:8 Topics: Anti-Inflammatory Agents; Carrier Proteins; Cerebrospinal Fluid; Disorders of Excessive Somnolence; Female; Humans; Hypothalamic Diseases; Intracellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuropeptides; Orexins; Pulse Therapy, Drug; Treatment Outcome	2003
Changes in cerebrospinal fluid of patients with multiple sclerosis after treatment with intrathecal methylprednisolone acetate: a preliminary report. Proceedings of the staff meetings. Mayo Clinic, 1962, Dec-05, Volume: 37 Topics: Cerebrospinal Fluid Proteins; gamma-Globulins; Humans; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis	1962
Predictable remissions in multiple sclerosis. Delaware medical journal, 1963, Volume: 35 Topics: Humans; Methylprednisolone; Multiple Sclerosis; Neoplasms	1963
TREATMENT OF MULTIPLE SCLEROSIS WITH INTRATHECAL STEROIDS. Neurology, 1964, Volume: 14 Topics: Drug Therapy; Humans; Injections, Spinal; Methylprednisolone; Multiple Sclerosis; Spinal Canal; Steroids	1964
ERRATIC PERSISTANCE OF INTRATHECALLY INJECTED METHYLPREDNISOLONE ACETATE. Delaware medical journal, 1964, Volume: 36 Topics: 17-Hydroxycorticosteroids; Cerebrospinal Fluid; Diet; Diet Therapy; Humans; Injections, Spinal; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis	1964
FATE OF ADRENAL CORTICAL STEROIDS FOLLOWING INTRATHECAL INJECTION. Neurology, 1965, Volume: 15 Topics: Adrenal Cortex Hormones; Animals; Biological Transport; Blood Chemical Analysis; Blood-Brain Barrier; Cerebrospinal Fluid; Demyelinating Diseases; Dogs; Drug Therapy; Hydrocortisone; Injections; Injections, Spinal; Metabolism; Methylprednisolone; Multiple Sclerosis; Research	1965
USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY. Archives of neurology, 1965, Volume: 12 Topics: Adrenal Cortex Hormones; Biomedical Research; Double-Blind Method; Drug Therapy; Humans; Methylprednisolone; Multiple Sclerosis; Vitamin B 12	1965
LARGE DOSE CORTICOSTEROID THERAPY OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES. Annals of the New York Academy of Sciences, 1965, Mar-31, Volume: 122 Topics: Adrenal Cortex Hormones; Animals; Demyelinating Diseases; Drug Therapy; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Humans; Methylprednisolone; Multiple Sclerosis; Prednisone; Rabbits	1965
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL. Annals of the New York Academy of Sciences, 1965, Mar-31, Volume: 122 Topics: Adrenocorticotropic Hormone; Biomedical Research; Drug Therapy; Fluprednisolone; Humans; Methylprednisolone; Multiple Sclerosis; Nervous System; Nervous System Physiological Phenomena; Neurologic Examination; Research; Vitamin B 12	1965
[A case of multiple sclerosis with incongruous homonymous hemianopia due to lateral geniculate body lesion]. Rinsho shinkeigaku = Clinical neurology, 2003, Volume: 43, Issue:6 Topics: Adult; Central Nervous System; Female; Hemianopsia; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Pulse Therapy, Drug; Treatment Outcome	2003
Ophthaproblem. Optic neuritis. Canadian family physician Medecin de famille canadien, 2003, Volume: 49 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Pain; Remission, Spontaneous	2003
Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the neurological sciences, 2004, Mar-15, Volume: 218, Issue:1-2 Topics: Adult; Aftercare; Cross-Sectional Studies; Disability Evaluation; Drug Administration Schedule; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Neuroprotective Agents; Neuropsychological Tests; Prospective Studies; Quality of Life; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Sickness Impact Profile; Statistics as Topic; Surveys and Questionnaires; Time Factors; Treatment Outcome	2004
Neuroretinitis in patients with multiple sclerosis. Ophthalmology, 2004, Volume: 111, Issue:2 Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Retinitis; Retrospective Studies; Visual Acuity	2004
[Treatment of relapsing multiple sclerosis during pregnancy]. Duodecim; laaketieteellinen aikakauskirja, 2004, Volume: 120, Issue:4 Topics: Adult; Dose-Response Relationship, Drug; Female; Fetal Death; Follow-Up Studies; Gestational Age; Humans; Methylprednisolone; Multiple Sclerosis; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, High-Risk	2004
CD95/Fas expression on peripheral blood T lymphocytes in patients with multiple sclerosis: effect of high-dose methylprednisolone therapy. Clinical neurology and neurosurgery, 2004, Volume: 106, Issue:3 Topics: Anti-Inflammatory Agents; CD4 Antigens; CD8 Antigens; Dose-Response Relationship, Drug; fas Receptor; Flow Cytometry; Humans; Immunophenotyping; Methylprednisolone; Multiple Sclerosis; Recurrence; Remission Induction; T-Lymphocytes	2004
[Neuromyelitis optica (Devic's disease): a severe variant of multiple sclerosis]. Nederlands tijdschrift voor geneeskunde, 2004, May-29, Volume: 148, Issue:22 Topics: Adult; Diagnosis, Differential; Fatal Outcome; Female; Humans; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Neuroprotective Agents	2004
Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. Journal of neurology, 2004, Volume: 251, Issue:7 Topics: Adult; Carrier Proteins; Disorders of Excessive Somnolence; Down-Regulation; Female; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Methylprednisolone; Multiple Sclerosis; Neuropeptides; Orexins; REM Sleep Parasomnias; Treatment Outcome	2004
Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2004, Volume: 10, Issue:4 Topics: Adult; Disability Evaluation; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2004
[Preventing the vacation trip from becoming a horror trip. Travel recommendations for neurologic patients]. MMW Fortschritte der Medizin, 2004, May-20, Volume: 146, Issue:21 Topics: Adjuvants, Immunologic; Combined Modality Therapy; Drug Stability; Drug Storage; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis; Travel; Vaccines, Inactivated	2004
The coexistence of familial Mediterranean fever with multiple sclerosis. European journal of neurology, 2004, Volume: 11, Issue:10 Topics: Adult; Familial Mediterranean Fever; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents	2004
Suppression of immune system genes by methylprednisolone in exacerbations of multiple sclerosis. Preliminary results. Journal of neurology, 2004, Volume: 251, Issue:10 Topics: Adult; Anti-Inflammatory Agents; CD5 Antigens; DNA-Binding Proteins; Eosinophil-Derived Neurotoxin; Female; Gene Expression Regulation; Humans; Immune System; Interferon-Stimulated Gene Factor 3; Interferon-Stimulated Gene Factor 3, gamma Subunit; Lymphoid Enhancer-Binding Factor 1; Male; Methylprednisolone; Multiple Sclerosis; Oligonucleotide Array Sequence Analysis; Protein-Tyrosine Kinases; RNA; Transcription Factors	2004
Panuveitis associated with multiple sclerosis complicated by cerebral venous thrombosis. Ocular immunology and inflammation, 2004, Volume: 12, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Cerebral Veins; Female; Fluorescein Angiography; Fundus Oculi; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Panuveitis; Phlebitis; Retinal Vein; Venous Thrombosis	2004
Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 2 Topics: Animals; Drug Therapy, Combination; Electroretinography; Encephalomyelitis, Autoimmune, Experimental; Erythropoietin; Evoked Potentials, Visual; Female; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents; Optic Nerve; Optic Neuritis; Rats; Rats, Inbred BN; Recombinant Proteins; Retinal Ganglion Cells; Signal Transduction	2005
Effect of corticosteroids on short-term and long-term memory. Neurology, 2005, Jan-25, Volume: 64, Issue:2 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Attention; Female; Hippocampus; Humans; Male; Memory; Memory Disorders; Memory, Short-Term; Mental Recall; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuropsychological Tests; Optic Neuritis; Stress, Physiological; Verbal Learning	2005
Riedel's thyroiditis in a patient with multiple sclerosis. Neuro endocrinology letters, 2005, Volume: 26, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Brain; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Thyroiditis, Autoimmune	2005
[Optic neuritis--diagnosis, treatment and follow up]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2005, Feb-17, Volume: 125, Issue:4 Topics: Diagnosis, Differential; Follow-Up Studies; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Practice Guidelines as Topic; Risk Factors; Visual Acuity	2005
Optic neuritis and multiple sclerosis: long-term prognostic considerations. Archives of neurology, 2005, Volume: 62, Issue:3 Topics: Follow-Up Studies; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prognosis; Time Factors	2005
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology, 2005, Mar-22, Volume: 64, Issue:6 Topics: Administration, Oral; Anti-Inflammatory Agents; Biological Availability; Central Nervous System; Clinical Protocols; Humans; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Prednisone	2005
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. European journal of neurology, 2005, Volume: 12, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Female; Femur Neck; Humans; Injections, Intravenous; Lumbosacral Region; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Osteoporosis; Spine; Time	2005
High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients. Journal of neuroimmunology, 2005, Volume: 167, Issue:1-2 Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Female; Flow Cytometry; Granulocytes; Humans; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis; Receptors, IgG; Statistics, Nonparametric; Time Factors	2005
Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers. Thrombosis and haemostasis, 2005, Volume: 94, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Factor VIII; Female; Fibrinogen; Fibrinolysis; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisone; Risk Factors; Thromboembolism; Time Factors; von Willebrand Factor	2005
X-linked Charcot-Marie-Tooth disease and progressive-relapsing central demyelinating disease. Neurology, 2005, Nov-22, Volume: 65, Issue:10 Topics: Adult; Brain; Brain Stem; Cerebellum; Charcot-Marie-Tooth Disease; Connexins; Diagnosis, Differential; Disease Progression; DNA Mutational Analysis; Gap Junction beta-1 Protein; Genetic Diseases, X-Linked; Genetic Predisposition to Disease; Genetic Testing; Hereditary Central Nervous System Demyelinating Diseases; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Mutation; Oligoclonal Bands; Recurrence; Treatment Failure	2005
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients]. Der Nervenarzt, 2006, Volume: 77, Issue:4 Topics: Activities of Daily Living; Adolescent; Adult; Anti-Inflammatory Agents; Brain; Child; Combined Modality Therapy; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Neuromyelitis Optica; Plasma Exchange; Recurrence; Retrospective Studies	2006
Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis. Ophthalmology, 2006, Volume: 113, Issue:2 Topics: Acute Disease; Adult; Cross-Sectional Studies; Evoked Potentials, Visual; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Pulse Therapy, Drug; ROC Curve; Sensitivity and Specificity	2006
Postpartum activation of multiple sclerosis: MRI imaging and immunological characterization of a case. European journal of neurology, 2006, Volume: 13, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Lymphocytes; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Postpartum Period; Time Factors; Tomography, X-Ray Computed	2006
Pediatric multiple sclerosis. Mayo Clinic proceedings, 2006, Volume: 81, Issue:2 Topics: Adjuvants, Immunologic; Adolescent; Female; Humans; Interferon beta-1a; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents	2006
Intractable hiccups induced by high-dose intravenous methylprednisolone in a patient with multiple sclerosis. European journal of neurology, 2006, Volume: 13, Issue:2 Topics: Anti-Inflammatory Agents; Hiccup; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methylprednisolone; Middle Aged; Multiple Sclerosis	2006
[Effect of methylprednisolone on the attention in patients with multiple sclerosis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2006, Volume: 20, Issue:115 Topics: Adult; Anti-Inflammatory Agents; Attention; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Reaction Time	2006
Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. Journal of neuroimmunology, 2006, Volume: 176, Issue:1-2 Topics: Adolescent; Adult; Dendritic Cells; Female; HLA-DR Antigens; Humans; Injections, Intravenous; Lymphocyte Activation; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; T-Lymphocytes, Regulatory	2006
Etanercept induced multiple sclerosis and transverse myelitis. The Journal of rheumatology, 2006, Volume: 33, Issue:6 Topics: Antirheumatic Agents; Brain; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelitis, Transverse; Receptors, Tumor Necrosis Factor; Spinal Cord; Treatment Outcome	2006
An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotes. Statistics in medicine, 2007, Apr-30, Volume: 26, Issue:9 Topics: Azathioprine; Calcitriol; Computer Simulation; Drug Therapy, Combination; Humans; Hyperparathyroidism; Immunosuppressive Agents; Linear Models; Longitudinal Studies; Methylprednisolone; Multiple Sclerosis; Parathyroid Hormone; Randomized Controlled Trials as Topic; Receptors, Fc	2007
Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy. Journal of the neurological sciences, 2007, May-15, Volume: 256, Issue:1-2 Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Disability Evaluation; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Psychometrics; Quality of Life; Severity of Illness Index; Sickness Impact Profile; Surveys and Questionnaires; Time Factors	2007
Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids. Multiple sclerosis (Houndmills, Basingstoke, England), 2007, Volume: 13, Issue:4 Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents; Brain; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis	2007
Pathogenetic role of myelitis for syringomyelia. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:6 Topics: Adult; Back Pain; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Neck Pain; Neurologic Examination; Neuromyelitis Optica; Paresthesia; Prednisone; Quadriplegia; Recurrence; Sarcoidosis; Spinal Cord; Syringomyelia	2007
[Coincidence of juvenile idiopathic arthritis and multiple sclerosis: case report]. Annales Academiae Medicae Stetinensis, 2006, Volume: 52 Suppl 2 Topics: Adult; Arthritis, Juvenile; Brain; Female; Humans; Interferon-beta; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Multiple Sclerosis; Treatment Outcome	2006
[Multiple sclerosis in children]. Nederlands tijdschrift voor geneeskunde, 2007, Jun-30, Volume: 151, Issue:26 Topics: Child; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Interferon-beta; Male; Methylprednisolone; Multiple Sclerosis; Paresis	2007
The clock keeps ticking for intravenous methylprednisolone. Journal of neurology, neurosurgery, and psychiatry, 2007, Volume: 78, Issue:8 Topics: Anti-Inflammatory Agents; Circadian Rhythm; Humans; Methylprednisolone; Multiple Sclerosis; Time Factors	2007
Prognosis of Taiwanese patients with isolated optic neuritis after intravenous methylprednisolone pulse therapy. Journal of the Formosan Medical Association = Taiwan yi zhi, 2007, Volume: 106, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prognosis; Pulse Therapy, Drug; Recurrence; Retrospective Studies	2007
Teaching NeuroImage: the L5 spinal cord segment. Neurology, 2007, Oct-09, Volume: 69, Issue:15 Topics: Adult; Demyelinating Autoimmune Diseases, CNS; Disease Progression; Education, Medical, Graduate; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Muscle Weakness; Muscle, Skeletal; Radiculopathy; Spinal Cord; Treatment Outcome	2007
Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC. Journal of clinical immunology, 2008, Volume: 28, Issue:2 Topics: Adult; Dose-Response Relationship, Drug; Female; Gene Expression; Humans; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Receptors, CXCR; Receptors, CXCR3; Receptors, CXCR4; Receptors, CXCR5; Receptors, Interleukin-8A; Receptors, Interleukin-8B	2008
Recurrent headache due to MS plaque. Headache, 2008, Volume: 48, Issue:3 Topics: Analgesics, Opioid; Anti-Inflammatory Agents; Female; Headache; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Morphine; Multiple Sclerosis; Procaine; Spinal Cord; Sumatriptan	2008
Baló's concentric sclerosislike lesion in the brainstem of a multiple sclerosis patient. Journal of neurology, 2008, Volume: 255, Issue:5 Topics: Anti-Inflammatory Agents; Ataxia; Brain Stem; Cerebrum; Diagnosis, Differential; Diffuse Cerebral Sclerosis of Schilder; Disease Progression; Dysarthria; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Ocular Motility Disorders; Paresis; Spinal Cord; Treatment Outcome	2008
The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis. Acta neurologica Scandinavica, 2008, Volume: 118, Issue:2 Topics: Analgesics; Central Nervous System; Chemokine CCL5; Chemotaxis, Leukocyte; Glucocorticoids; Humans; In Vitro Techniques; Lymphocytes; Methylprednisolone; Mitoxantrone; Multiple Sclerosis	2008
A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2008, Volume: 29, Issue:1 Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Brain; Celiac Disease; Female; Glatiramer Acetate; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Peptides	2008
Allergic and nonallergic delayed infusion reactions during natalizumab therapy. Archives of neurology, 2008, Volume: 65, Issue:5 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoantibodies; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Immunologic Factors; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Natalizumab; Treatment Outcome	2008
Intrathecal methylprednisolone for multiple sclerosis: evaluation by a standard neurological rating. Annals of allergy, 1967, Volume: 25, Issue:12 Topics: Adult; Female; Humans; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Spinal Puncture	1967
Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology, 1980, Volume: 30, Issue:7 Pt 2 Topics: Acute Disease; Adolescent; Adrenocorticotropic Hormone; Adult; Demyelinating Diseases; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Polyradiculoneuropathy; Prednisone	1980
Anaphylactoid reaction to methylprednisolone pulsed therapy for multiple sclerosis. Neurology, 1984, Volume: 34, Issue:8 Topics: Anaphylaxis; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1984
Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis. Annals of neurology, 1984, Volume: 15, Issue:3 Topics: Adult; Female; Humans; Injections, Intravenous; Iothalamate Meglumine; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisone; Time Factors; Tomography, X-Ray Computed	1984
High dose intravenous methyl prednisolone in acute exacerbations of multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1983, Volume: 46, Issue:1 Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis	1983
Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production. Italian journal of neurological sciences, 1982, Volume: 3, Issue:2 Topics: Adult; Biological Transport; Blood Proteins; Cerebrospinal Fluid Proteins; Female; Humans; Immunoglobulin G; Injections, Spinal; Isoelectric Focusing; Male; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis	1982
Prolonged effects of large-dose methylprednisolone infusion in multiple sclerosis. Neurology, 1980, Volume: 30, Issue:7 Pt 1 Topics: B-Lymphocytes; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Female; Hematocrit; Humans; Hydrocortisone; Immunoglobulin G; Leukocyte Count; Lymphocyte Activation; Male; Methylprednisolone; Multiple Sclerosis; T-Lymphocytes; Time Factors	1980
Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone. Journal of neurology, neurosurgery, and psychiatry, 1982, Volume: 45, Issue:2 Topics: Acute Disease; Adolescent; Adult; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1982
Methylprednisolone therapy in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1982, Volume: 45, Issue:10 Topics: Humans; Methylprednisolone; Multiple Sclerosis; Prognosis	1982
Methylprednisolone infusion during acute exacerbation of MS: plasma and CSF concentrations. European neurology, 1995, Volume: 35, Issue:3 Topics: Adult; Blood-Brain Barrier; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination	1995
[Neuro-ophthalmology--new challenges]. Klinika oczna, 1995, Volume: 97, Issue:5 Topics: Administration, Oral; Counseling; Humans; Methylprednisolone; Multiple Sclerosis; Optic Nerve Diseases; Optic Neuritis; Prednisone; Pseudotumor Cerebri	1995
Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment. Annals of neurology, 1993, Volume: 33, Issue:1 Topics: Adult; Aged; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Predictive Value of Tests; Prednisone; Regression Analysis; Treatment Outcome	1993
Intravenous methylprednisolone for exacerbations in multiple sclerosis. Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 1995, Volume: 4, Issue:3 Topics: Humans; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Remission Induction	1995
Follow-up study of MS patients treated with high-dose intravenous methylprednisolone. Acta neurologica Scandinavica, 1994, Volume: 90, Issue:2 Topics: Adult; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunoglobulins; Infusions, Intravenous; Longitudinal Studies; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Oligoclonal Bands; Prednisone; Prospective Studies; Recurrence	1994
High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients. The International journal of neuroscience, 1994, Volume: 75, Issue:1-2 Topics: Adult; CD4-Positive T-Lymphocytes; CD8 Antigens; Cell Adhesion Molecules; Cerebrospinal Fluid; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Interleukin-2; Leukocyte Count; Lymphocyte Subsets; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis	1994
The effect of methylprednisolone on monocyte eicosanoid production in patients with multiple sclerosis. Journal of neurology, 1994, Volume: 241, Issue:7 Topics: Adult; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Immunologic; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Leukotriene B4; Male; Methylprednisolone; Monocytes; Multiple Sclerosis; Pokeweed Mitogens; Radioimmunoassay; Thromboxane B2	1994
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis. Neuroradiology, 1994, Volume: 36, Issue:5 Topics: Adult; Brain; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Time Factors	1994
Megadose steroids in multiple sclerosis. Neurology, 1994, Volume: 44, Issue:10 Topics: Clinical Trials as Topic; Humans; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Research Design	1994
The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link. The International journal of neuroscience, 1994, Volume: 76, Issue:3-4 Topics: Adult; Aged; Blood-Brain Barrier; Brain; Calcinosis; Female; Humans; Melatonin; Methylprednisolone; Migraine Disorders; Multiple Sclerosis; Pineal Gland; Recurrence; Serotonin	1994
What have the optic neuritis treatment trial and the longitudinal optic neuritis study shown us? Journal of the neurological sciences, 1994, Volume: 125, Issue:1 Topics: Administration, Oral; Clinical Trials as Topic; Cohort Studies; Follow-Up Studies; Humans; Injections, Intravenous; Longitudinal Studies; Magnetic Resonance Imaging; Methylprednisolone; Multicenter Studies as Topic; Multiple Sclerosis; Optic Neuritis; Prednisone	1994
Micrographia associated with a parietal lobe lesion in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:6 Topics: Brain Diseases; Female; Handwriting; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pain; Paresthesia; Parietal Lobe; Thigh	1994
Chlorpromazine prophylaxis of steroid-induced psychosis. General hospital psychiatry, 1994, Volume: 16, Issue:1 Topics: Adult; Chlorpromazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Methylprednisolone; Multiple Sclerosis; Premedication; Psychoses, Substance-Induced	1994
Intractable hiccups and sleep apnea syndrome in multiple sclerosis: report of two cases. Acta neurologica Scandinavica, 1993, Volume: 88, Issue:6 Topics: Amitriptyline; Female; Hiccup; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methylprednisolone; Middle Aged; Multiple Sclerosis; Radiography; Sleep Apnea Syndromes	1993
Corticosteroids, optic neuritis, and multiple sclerosis. The New England journal of medicine, 1994, Apr-28, Volume: 330, Issue:17 Topics: Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone	1994
[Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al]. Der Nervenarzt, 1994, Volume: 65, Issue:2 Topics: Adrenal Cortex Hormones; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypothalamo-Hypophyseal System; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Pituitary-Adrenal System	1994
Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology, 1993, Volume: 43, Issue:6 Topics: Adult; Demyelinating Diseases; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Plasmapheresis; Retrospective Studies; Treatment Outcome	1993
Eye movement quantitative evaluation before and after high-dose 6-methylprednisolone in multiple sclerosis. Acta neurologica Scandinavica, 1994, Volume: 89, Issue:2 Topics: Adult; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Photic Stimulation; Reproducibility of Results; Saccades; Task Performance and Analysis; Treatment Outcome	1994
Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. Acta neurologica Scandinavica, 1994, Volume: 89, Issue:2 Topics: Adolescent; Antibodies, Monoclonal; Antigens, CD; Enzyme-Linked Immunosorbent Assay; Female; HLA-DR Antigens; Humans; Interleukin-2; Longitudinal Studies; Male; Methylprednisolone; Multiple Sclerosis; T-Lymphocytes	1994
T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Acta neurologica Scandinavica, 1993, Volume: 88, Issue:2 Topics: Adrenal Cortex Hormones; Adult; B-Lymphocytes; Cerebrospinal Fluid; Chronic Disease; Demyelinating Diseases; Female; Humans; Injections, Intravenous; Intervertebral Disc Displacement; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; T-Lymphocytes	1993
Corticosteroids and optic neuritis. The New England journal of medicine, 1993, Dec-09, Volume: 329, Issue:24 Topics: Acute Disease; Anti-Inflammatory Agents; Bias; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; Research Design	1993
Vestibular evaluation--electronystagmography, rotational testing, and posturography. Clinical EEG (electroencephalography), 1993, Volume: 24, Issue:4 Topics: Adrenocorticotropic Hormone; Caloric Tests; Electronystagmography; Humans; Meniere Disease; Methylprednisolone; Multiple Sclerosis; Postural Balance; Posture; Reaction Time; Reflex, Vestibulo-Ocular; Rotation; Vestibular Diseases; Vestibular Function Tests; Vestibular Nerve	1993
High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial. Archives of ophthalmology (Chicago, Ill. : 1960), 1994, Volume: 112, Issue:1 Topics: Acute Disease; Administration, Oral; Drug Administration Schedule; Humans; Incidence; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; Randomized Controlled Trials as Topic; Research Design	1994
Megadose corticosteroids in multiple sclerosis. Neurology, 1994, Volume: 44, Issue:1 Topics: Adrenal Cortex Hormones; Brain; Clinical Trials as Topic; Cohort Studies; Humans; Injections, Intravenous; Longitudinal Studies; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Prednisone; Pulsatile Flow	1994
Corticosteroids and optic neuritis. Neurology, 1993, Volume: 43, Issue:3 Pt 1 Topics: Administration, Oral; Adolescent; Adrenocorticotropic Hormone; Child; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; T-Lymphocytes	1993
Oral megadose methylprednisolone therapy in a patient with chronic progressive multiple sclerosis. Neurology, 1993, Volume: 43, Issue:1 Topics: Administration, Oral; Adolescent; Female; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Recurrence	1993
Intraspinal therapy using methylprednisolone acetate. Twenty-three years of clinical controversy. Spine, 1993, Volume: 18, Issue:2 Topics: Anesthesiology; Anti-Inflammatory Agents; Arachnoiditis; History, 20th Century; Humans; Low Back Pain; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis; Neurology; Neurosurgery; Sciatica	1993
High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up. Acta neurologica, 1993, Volume: 15, Issue:1 Topics: Adolescent; Adult; Chronic Disease; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Physical Therapy Modalities; Recurrence	1993
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Annals of neurology, 1993, Volume: 33, Issue:5 Topics: Adult; Brain; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prednisone; Recurrence; Remission, Spontaneous; Spine; Time Factors; Visual Acuity	1993
Decline of muscle fiber conduction velocity during short-term high-dose methylprednisolone therapy. Muscle & nerve, 1996, Volume: 19, Issue:1 Topics: Adult; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Muscles; Neural Conduction; Time Factors	1996
Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis. Japanese journal of ophthalmology, 1995, Volume: 39, Issue:3 Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Child; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelitis, Transverse; Optic Neuritis; Visual Acuity	1995
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain : a journal of neurology, 1996, Volume: 119 ( Pt 1) Topics: Adult; Alemtuzumab; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Blood Cell Count; Body Temperature; C-Reactive Protein; CD4 Antigens; Complement Activation; Complement Hemolytic Activity Assay; Cytokines; Female; Humans; Lymphopenia; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Neural Conduction; Sheep	1996
Primary CNS demyelinating diseases in childhood: multiple sclerosis. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1996, Volume: 12, Issue:3 Topics: Adolescent; Anti-Inflammatory Agents; Brain; Child; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Spinal Puncture	1996
Optic neuritis treatment trial. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1995, Volume: 15, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Optic Neuritis	1995
CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis. Journal of neurology, 1996, Volume: 243, Issue:6 Topics: Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Female; Humans; Injections, Intravenous; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Methylprednisolone; Multiple Sclerosis; Neuroprotective Agents	1996
Methylprednisolone attenuates interferon-beta induced expression of HLA-DR on monocytes. Journal of neuroimmunology, 1996, Volume: 70, Issue:1 Topics: Autoimmune Diseases; Gene Expression Regulation; HLA-DR Antigens; Humans; Immunosuppressive Agents; Interferon-beta; Interferon-gamma; Male; Methylprednisolone; Monocytes; Multiple Sclerosis; Recombinant Proteins	1996
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1996, Volume: 61, Issue:4 Topics: Anti-Inflammatory Agents; Blood-Brain Barrier; Dose-Response Relationship, Drug; Humans; Methylprednisolone; Multiple Sclerosis; Recurrence	1996
Grand rounds--Hammersmith Hospitals. Distinguishing acute disseminated encephalomyelitis from multiple sclerosis. BMJ (Clinical research ed.), 1996, Sep-28, Volume: 313, Issue:7060 Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Prognosis	1996
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. Journal of neuroimmunology, 1996, Volume: 66, Issue:1-2 Topics: Adult; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Receptors, Tumor Necrosis Factor; Recurrence; Tumor Necrosis Factor-alpha	1996
Oral or intravenous methylprednisolone for acute relapses of MS? Lancet (London, England), 1997, Mar-29, Volume: 349, Issue:9056 Topics: Administration, Oral; Glucocorticoids; Humans; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Recurrence	1997
The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patients. Acta neurologica Scandinavica, 1997, Volume: 95, Issue:4 Topics: Adult; Female; Gadolinium; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Remission, Spontaneous; Sensitivity and Specificity	1997
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis. Lancet (London, England), 1997, Jun-07, Volume: 349, Issue:9066 Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Dexamethasone; Disability Evaluation; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Treatment Outcome	1997
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis. Lancet (London, England), 1997, Jun-07, Volume: 349, Issue:9066 Topics: Administration, Oral; Glucocorticoids; Humans; Infusions, Intravenous; Methylprednisolone; Multiple Sclerosis; Prednisolone	1997
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis. Lancet (London, England), 1997, Jun-07, Volume: 349, Issue:9066 Topics: Administration, Oral; Glucocorticoids; Humans; Infusions, Parenteral; Methylprednisolone; Multiple Sclerosis; Treatment Outcome	1997
Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone. Acta neurologica Scandinavica, 1997, Volume: 95, Issue:5 Topics: Adult; Anti-Inflammatory Agents; CD8 Antigens; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Injections, Intravenous; Intercellular Adhesion Molecule-1; Male; Methylprednisolone; Multiple Sclerosis; Severity of Illness Index	1997
Multiple sclerosis: a consideration in acute cranial nerve palsies. The American journal of otology, 1997, Volume: 18, Issue:5 Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Brain Stem; Demyelinating Diseases; Female; Hearing Loss, Sensorineural; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Paralysis; Severity of Illness Index; Vestibular Nerve; Vestibulocochlear Nerve	1997
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia. Annals of neurology, 1997, Volume: 42, Issue:3 Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Interferon-beta; Interleukin-4; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis	1997
Childhood multiple sclerosis treated with plasmapheresis. Pediatric neurology, 1997, Volume: 17, Issue:1 Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Brain; Child; Combined Modality Therapy; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Plasmapheresis	1997
IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings. Italian journal of neurological sciences, 1997, Volume: 18, Issue:4 Topics: Adult; Aged; Case-Control Studies; Female; Humans; Interleukin-10; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisone	1997
Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 1995, Volume: 1, Issue:1 Topics: Adjuvants, Immunologic; Adult; Antigens, CD; Female; Glucocorticoids; HLA-DR Antigens; Humans; Injections, Intravenous; Interferon-gamma; Interleukin-2; Lymphocyte Count; Lymphocyte Subsets; Male; Methylprednisolone; Middle Aged; Mitogens; Multiple Sclerosis; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Time Factors	1995
[Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone]. Rinsho shinkeigaku = Clinical neurology, 1997, Volume: 37, Issue:7 Topics: Adult; Female; Humans; Injections, Intravenous; Interferon-gamma; Interleukin-2; Interleukin-4; Lymphocyte Count; Lymphocytes; Male; Methylprednisolone; Multiple Sclerosis; Receptors, Interleukin-2; Recurrence	1997
Reduced adhesion of PBMNCs to endothelium in methylprednisolone-treated MS patients: preliminary results. Acta neurologica Scandinavica, 1997, Volume: 96, Issue:5 Topics: Adult; Anti-Inflammatory Agents; CD18 Antigens; Cell Adhesion; Cells, Cultured; Disease Progression; Endothelium, Vascular; Female; Humans; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Lipopolysaccharide Receptors; Lymphocyte Function-Associated Antigen-1; Lymphocyte Subsets; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis; Vascular Cell Adhesion Molecule-1	1997
Anaphylactoid reaction to intravenous methylprednisolone in a patient with multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:6 Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents; Female; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis	1997
[A case of multiple sclerosis with relapses during the third trimester of pregnancy]. Rinsho shinkeigaku = Clinical neurology, 1997, Volume: 37, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Cesarean Section; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Recurrence	1997
Homonymous hemianopsia as the initial manifestation of multiple sclerosis. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1998, Volume: 212, Issue:3 Topics: Adult; Evoked Potentials, Visual; Glucocorticoids; Hemianopsia; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Occipital Lobe; Parietal Lobe; Visual Fields	1998
Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. Journal of neuroimmunology, 1998, May-15, Volume: 85, Issue:2 Topics: Acute Disease; Adult; Female; Glucocorticoids; Humans; Interleukin-10; Lipopolysaccharides; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; RNA, Messenger	1998
[Acute disseminated bulbospinal encephalomyelitis in an adult patient]. Revista de neurologia, 1998, Volume: 26, Issue:154 Topics: Acute Disease; Adult; Age of Onset; Anti-Inflammatory Agents; Diagnosis, Differential; Encephalomyelitis; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Reye Syndrome	1998
Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon beta-1b in patients with relapsing-remitting multiple sclerosis. Annals of neurology, 1998, Volume: 44, Issue:1 Topics: Administration, Oral; Adult; Case-Control Studies; Female; Glucocorticoids; Humans; Incidence; Injections, Intravenous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Neuroprotective Agents; Prednisone; Recombinant Proteins; Recurrence; Retrospective Studies	1998
Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients. Clinical immunology and immunopathology, 1998, Volume: 88, Issue:1 Topics: Adult; Autoantigens; Cell Line; Cyclophosphamide; Female; Humans; Interleukin-4; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Myelin Proteolipid Protein; Tetanus Toxoid; Th2 Cells	1998
Methylprednisolone-induced neutrophil leukocytosis--down-modulation of neutrophil L-selectin and Mac-1 expression and induction of granulocyte-colony stimulating factor. International journal of clinical & laboratory research, 1998, Volume: 28, Issue:2 Topics: Down-Regulation; Granulocyte Colony-Stimulating Factor; Humans; L-Selectin; Leukocytosis; Macrophage-1 Antigen; Methylprednisolone; Multiple Sclerosis; Neutrophils	1998
Cost analysis of methylprednisolone treatment of multiple sclerosis patients. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1998, Volume: 25, Issue:3 Topics: Ambulatory Care; Anti-Inflammatory Agents; Canada; Costs and Cost Analysis; Fees, Medical; Home Care Services; Hospitalization; Humans; Methylprednisolone; Multiple Sclerosis	1998
Corticosteroids and multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:3 Topics: Adrenocorticotropic Hormone; Humans; Injections, Intramuscular; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Recurrence; United Kingdom	1998
Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom. Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:3 Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Humans; Injections, Intramuscular; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Patient Care Team; Pilot Projects; Recurrence; United Kingdom	1998
[Multiple sclerosis in childhood: our experience and a review of literature]. Revista de neurologia, 1998, Volume: 27, Issue:156 Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Child; Child, Preschool; Cosyntropin; Diagnosis, Differential; Female; Hemiplegia; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed	1998
The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment. Multiple sclerosis (Houndmills, Basingstoke, England), 1998, Volume: 4, Issue:3 Topics: Adjuvants, Immunologic; Adult; Case-Control Studies; HLA-DR Antigens; Humans; Injections, Intravenous; Integrin alpha4beta1; Integrins; Lymphocyte Activation; Lymphocyte Function-Associated Antigen-1; Methylprednisolone; Multiple Sclerosis; Receptors, Lymphocyte Homing; Recurrence; T-Lymphocytes	1998
A phase II study of IV methylprednisolone in secondary progressive MS. Neurology, 1999, Mar-10, Volume: 52, Issue:4 Topics: Anti-Inflammatory Agents; Clinical Trials, Phase II as Topic; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis	1999
Isolation and identification of the C6-hydroxy and C20-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapy. Journal of chromatography. B, Biomedical sciences and applications, 1999, Apr-16, Volume: 726, Issue:1-2 Topics: Chromatography, High Pressure Liquid; Humans; Methylprednisolone; Multiple Sclerosis; Spectrum Analysis	1999
Disappearance of hypointense multiple sclerotic lesions on FLAIR MRI. Pediatric neurology, 1999, Volume: 21, Issue:1 Topics: Adolescent; Anti-Inflammatory Agents; Brain; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Remission Induction	1999
Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils. Neurological research, 1999, Volume: 21, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Demyelinating Diseases; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neutrophils; Superoxides; Tetradecanoylphorbol Acetate	1999
Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone. European cytokine network, 1999, Volume: 10, Issue:3 Topics: Adult; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha	1999
High-performance liquid chromatography analysis, preliminary pharmacokinetics, metabolism and renal excretion of methylprednisolone with its C6 and C20 hydroxy metabolites in multiple sclerosis patients receiving high-dose pulse therapy. Journal of chromatography. B, Biomedical sciences and applications, 1999, Sep-24, Volume: 732, Issue:2 Topics: Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Female; Humans; Kidney; Metabolic Clearance Rate; Methylprednisolone; Multiple Sclerosis	1999
An 11-year-old girl with syndrome of inappropriate antidiuretic hormone secretion. Seminars in pediatric neurology, 1999, Volume: 6, Issue:3 Topics: Amitriptyline; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Brain; Child; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Humans; Inappropriate ADH Syndrome; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Paresthesia; Spinal Cord	1999
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease. Multiple sclerosis (Houndmills, Basingstoke, England), 1999, Volume: 5, Issue:6 Topics: Adult; Age of Onset; Cycloheximide; Databases, Factual; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure	1999
Multiple sclerosis--Part 2. Treatment strategies. The Journal of the American Osteopathic Association, 1999, Volume: 99, Issue:12 Topics: Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methylprednisolone; Multiple Sclerosis; Recombinant Proteins; Treatment Outcome	1999
Acute disseminated encephalomyelitis in a pregnant woman successfully treated with plasmapheresis. Journal of the neurological sciences, 2000, Mar-15, Volume: 174, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Body Water; Combined Modality Therapy; Diagnosis, Differential; Diffusion; Encephalomyelitis, Acute Disseminated; Female; Gastroenteritis; Humans; Infant, Newborn; Labor, Induced; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Plasma Exchange; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Vision Disorders; Visual Fields	2000
[Magnetic resonance imaging and clinical features in adults with monophasic demyelinating disease. Acute disseminated encephalomyelitis or a variant of multiple sclerosis?]. Arquivos de neuro-psiquiatria, 1999, Volume: 57, Issue:3B Topics: Acute Disease; Adult; Demyelinating Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Retrospective Studies	1999
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology, 2000, May-09, Volume: 54, Issue:9 Topics: Administration, Oral; Adult; Alleles; Brain; Drug Therapy, Combination; Female; Haplotypes; HLA-DR2 Antigen; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Prednisone	2000
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology, 2000, Jun-13, Volume: 54, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Paralysis; Recombinant Proteins	2000
Postpartum optic neuritis: etiologic and pathophysiologic considerations. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2000, Volume: 20, Issue:2 Topics: Adult; Brain; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Postpartum Period; Prednisone; Puerperal Disorders; Vision Disorders; Visual Acuity	2000
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis. European journal of neurology, 2000, Volume: 7, Issue:3 Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Antigens; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immune System; Immunoglobulin G; Leukocyte Count; Male; Matrix Metalloproteinase 9; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Optic Neuritis; Randomized Controlled Trials as Topic; Spinal Cord; Spinal Puncture; Transforming Growth Factor beta	2000
Multiple sclerosis and syrinx formation. Acta neurologica Scandinavica, 2000, Volume: 101, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Syringomyelia	2000
[Serum anti-arrestin antibody and disease activity of multiple sclerosis--a case report of 4-year-old child]. No to hattatsu = Brain and development, 2000, Volume: 32, Issue:5 Topics: Arrestin; Autoantibodies; Biomarkers; Child, Preschool; Female; Humans; Methylprednisolone; Multiple Sclerosis; Prednisolone; Pulse Therapy, Drug; Recurrence; Remission Induction	2000
Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells. Journal of neuroimmunology, 2000, Oct-02, Volume: 110, Issue:1-2 Topics: Apoptosis; Autoantigens; Caspase 3; Caspases; CD4-Positive T-Lymphocytes; Coumarins; DNA Fragmentation; Fas Ligand Protein; fas Receptor; Fluorescent Dyes; Gene Expression; Glucocorticoids; Humans; Membrane Glycoproteins; Methylprednisolone; Multiple Sclerosis; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger	2000
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:5A Topics: Adult; Autoantibodies; Autoantigens; Autoimmune Diseases; Brain; Busulfan; Cells, Cultured; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Disease Progression; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunodominant Epitopes; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Lymphocyte Activation; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Sheath; T-Lymphocyte Subsets; Transplantation Conditioning; Treatment Outcome	2000
Isolated inferior rectus muscle palsy resulting from a nuclear third nerve lesion as the initial manifestation of multiple sclerosis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2000, Volume: 20, Issue:4 Topics: Adult; Diagnosis, Differential; Diplopia; Female; Glucocorticoids; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Oculomotor Muscles; Oculomotor Nerve Diseases	2000
High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Archives of neurology, 2001, Volume: 58, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Apoptosis; CD4-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Cytokines; Down-Regulation; Female; Flow Cytometry; Glucocorticoids; Humans; Killer Cells, Natural; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Proto-Oncogene Proteins c-bcl-2; Th1 Cells; Th2 Cells	2001
Susac's syndrome: beneficial effects of corticosteroid therapy in a Japanese case. Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Asian People; Asthma; Ataxia; Brain; Cognition Disorders; Confusion; Diagnosis, Differential; Diltiazem; Drug Therapy, Combination; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Papilledema; Prednisone; Reflex, Abnormal; Retinal Artery; Retinal Artery Occlusion; Skin Diseases, Vascular; Syndrome; Ticlopidine; Vasculitis, Central Nervous System	2001
Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2001, Volume: 7, Issue:1 Topics: Adjuvants, Immunologic; Autoimmune Diseases; Blood-Brain Barrier; Brain; Contrast Media; Cross-Over Studies; Drug Evaluation; Drug Therapy, Combination; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Intravenous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Treatment Outcome	2001
Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology, 2001, May-22, Volume: 56, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Brain; Cohort Studies; Cyclophosphamide; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prognosis; Tomography, X-Ray Computed; Treatment Outcome	2001
Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2001, Volume: 28, Issue:2 Topics: Adolescent; Adult; Antioxidants; Ceruloplasmin; Female; Glucocorticoids; Humans; Lipid Peroxidation; Male; Malondialdehyde; Methylprednisolone; Middle Aged; Multiple Sclerosis; Transferrin	2001
[Hospital-at-home as a solution for the treatment requirements of acute exacerbation in multiple sclerosis]. Harefuah, 2001, Volume: 140, Issue:7 Topics: Caregivers; Continuity of Patient Care; Cost-Benefit Analysis; Disease Progression; Family; Home Care Services; Humans; Injections, Intravenous; Israel; Methylprednisolone; Multiple Sclerosis; Patient Satisfaction; Safety	2001
The effect of corticosteroids on serum and cerebrospinal fluid nitric oxide levels in multiple sclerosis. Clinical chemistry and laboratory medicine, 2001, Volume: 39, Issue:9 Topics: Adolescent; Adult; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Nitric Oxide	2001
Comparison of the ONTT intravenous group and the CHAMPS placebo group. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2001, Volume: 21, Issue:4 Topics: Clinical Trials as Topic; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Optic Neuritis	2001
The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. 1997. Neurology, 2001, Volume: 57, Issue:12 Suppl 5 Topics: Female; History, 20th Century; Humans; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prednisone; Randomized Controlled Trials as Topic; Risk	2001
Immunoserological changes in the cerebro-spinal fluid and serum in systemic lupus erythematosus patients with demyelinating syndrome and multiple sclerosis. Acta neurologica Scandinavica, 2002, Volume: 105, Issue:5 Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Atrophy; Brain; Demyelinating Diseases; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunoglobulins; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prospective Studies	2002
Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis. Archives of neurology, 2002, Volume: 59, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Cell Migration Inhibition; Cell Movement; Cells, Cultured; Endothelium, Vascular; Female; Humans; Interferon-gamma; Leukocytes, Mononuclear; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Methylprednisolone; Middle Aged; Multiple Sclerosis; Receptors, Chemokine; Receptors, CXCR3; RNA, Messenger; Umbilical Veins	2002
Painful third nerve palsy in MS. Neurology, 2002, May-28, Volume: 58, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Methylprednisolone; Multiple Sclerosis; Oculomotor Nerve Diseases; Pain	2002
Multiple sclerosis update. Minnesota medicine, 2002, Volume: 85, Issue:6 Topics: Adjuvants, Immunologic; Combined Modality Therapy; Humans; Methylprednisolone; Multiple Sclerosis; Neurologic Examination; Plasma Exchange; Treatment Outcome	2002
Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid, or subdural spaces. Delaware medical journal, 1977, Volume: 49, Issue:6 Topics: Adult; Arachnoiditis; Female; Humans; Injections; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Orbit; Subdural Space	1977
[Considerations on intrathecal administration of corticosteroids in case of multiple sclerosis]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1976, Feb-01, Volume: 29, Issue:3 Topics: Adult; Humans; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1976
Sclerosing spinal pachymeningitis. A complication of intrathecal administration of Depo-Medrol for multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1976, Volume: 39, Issue:11 Topics: Adult; Cauda Equina; Cerebral Hemorrhage; Dura Mater; Female; Humans; Injections, Spinal; Meninges; Meningitis; Methylprednisolone; Multiple Sclerosis; Pharmaceutical Vehicles; Sclerosis; Spinal Cord; Subdural Space	1976
[Short-term effect of megadose steroid therapy in optic neuritis]. Klinische Monatsblatter fur Augenheilkunde, 1992, Volume: 201, Issue:6 Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Optic Neuritis; Visual Acuity; Visual Fields	1992
[A case of multiple sclerosis with intractable hiccups and sleep apnea syndrome]. Rinsho shinkeigaku = Clinical neurology, 1992, Volume: 32, Issue:7 Topics: Amitriptyline; Drug Administration Schedule; Female; Hiccup; Humans; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; Middle Aged; Multiple Sclerosis; Sleep Apnea Syndromes	1992
[Immunosuppressive treatment in multiple sclerosis]. Arquivos de neuro-psiquiatria, 1992, Volume: 50, Issue:3 Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisone; Retrospective Studies	1992
Intrathecal immunoglobulin synthesis in multiple sclerosis: effect of corticosteroids and azathioprine. European neurology, 1992, Volume: 32, Issue:6 Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Infusions, Intravenous; Injections, Intramuscular; Male; Methylprednisolone; Multiple Sclerosis; Prednisolone	1992
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Neurology, 1992, Volume: 42, Issue:1 Topics: Adult; Contrast Media; Disability Evaluation; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Organometallic Compounds; Pentetic Acid	1992
CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone. Acta neurologica Scandinavica, 1992, Volume: 86, Issue:3 Topics: Adult; Blood-Brain Barrier; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulin G; Immunoglobulin M; Infusions, Intravenous; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Neurologic Examination; Reference Values	1992
Intravenous gamma globulin in progressive MS. Acta neurologica Scandinavica, 1992, Volume: 86, Issue:2 Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunization, Passive; Immunoglobulin kappa-Chains; Immunoglobulin Light Chains; Immunoglobulins, Intravenous; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination	1992
Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis. Journal of the neurological sciences, 1992, Volume: 108, Issue:2 Topics: Adult; Arm; Electric Stimulation; Evoked Potentials; Female; Humans; Leg; Male; Methylprednisolone; Motor Neurons; Multiple Sclerosis; Muscle Contraction	1992
High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:6 Topics: Adult; Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Evoked Potentials, Visual; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Radiography; Refractive Errors	1992
[Cytokine production by peripheral blood monocytes/macrophages in the patients with multiple sclerosis and its suppression by methylprednisolone]. Rinsho shinkeigaku = Clinical neurology, 1992, Volume: 32, Issue:3 Topics: Adult; Cytokines; Depression, Chemical; Female; Humans; Interleukin-1; Interleukin-6; Macrophages; Male; Methylprednisolone; Middle Aged; Monocytes; Multiple Sclerosis; Tumor Necrosis Factor-alpha	1992
Prospects for the treatment of multiple sclerosis. Journal of the Royal Society of Medicine, 1991, Volume: 84, Issue:2 Topics: Adrenocorticotropic Hormone; Azathioprine; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis; Physical Therapy Modalities	1991
Sensitivity of eye movement registration and visual evoked potentials in evaluation of therapy in patients with multiple sclerosis. Journal of the neurological sciences, 1991, Volume: 102, Issue:1 Topics: Adult; Aged; Drug Evaluation; Evoked Potentials, Visual; Female; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Pursuit, Smooth; Reaction Time; Saccades; Severity of Illness Index	1991
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology, 1991, Volume: 41, Issue:8 Topics: Adult; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid	1991
The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions. Neurology, 1991, Volume: 41, Issue:9 Topics: Adult; Blood-Brain Barrier; Brain; Encephalomyelitis; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid	1991
A commentary on steroid treatment in multiple sclerosis. Archives of neurology, 1991, Volume: 48, Issue:10 Topics: Humans; Methylprednisolone; Multiple Sclerosis	1991
The effect of methylprednisolone on lymphocyte phenotype and function in patients with multiple sclerosis. Journal of neuroimmunology, 1990, Volume: 26, Issue:1 Topics: CD4-Positive T-Lymphocytes; Cells, Cultured; Concanavalin A; Female; Humans; Immunoglobulin G; Leukocyte Count; Lymphocytes; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Phenotype; Pokeweed Mitogens; Reference Values; T-Lymphocytes, Regulatory	1990
Relapsing transverse myelitis. Neurology, 1991, Volume: 41, Issue:5 Topics: Adolescent; Adult; Anti-Bacterial Agents; Dexamethasone; Female; Humans; Immunoglobulin G; Male; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Recurrence	1991
Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses. Acta neurologica Scandinavica, 1990, Volume: 81, Issue:6 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cortodoxone; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methylprednisolone; Metyrapone; Middle Aged; Multiple Sclerosis; Pituitary-Adrenal System; Prednisone; Recurrence	1990
Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters. Australian and New Zealand journal of medicine, 1990, Volume: 20, Issue:6 Topics: Adult; Albumins; Female; Humans; Immunoglobulin G; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Oligodendroglia; Recurrence; Serum Albumin	1990
[Magnetic resonance imaging after a one-month interval of lesions of multiple sclerosis in 2 populations, one during an acute attack treated with methylprednisolone, the other stable with no treatment]. Revue neurologique, 1990, Volume: 146, Issue:6-7 Topics: Follow-Up Studies; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Prospective Studies	1990
Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1986, Volume: 13, Issue:1 Topics: Adrenocorticotropic Hormone; Antibodies; Humans; Immunoglobulin G; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Radioimmunoassay	1986
[Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis]. EEG-EMG Zeitschrift fur Elektroenzephalographie, Elektromyographie und verwandte Gebiete, 1989, Volume: 20, Issue:2 Topics: Administration, Oral; Adult; Aged; Disability Evaluation; Electroencephalography; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Infusions, Intravenous; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Triamcinolone Acetonide	1989
Safety of intrathecal steroids in multiple sclerosis. Archives of neurology, 1989, Volume: 46, Issue:7 Topics: Anti-Inflammatory Agents; Humans; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis	1989
A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis. Acta neurologica Scandinavica, 1989, Volume: 80, Issue:6 Topics: Adolescent; Adult; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Optic Neuritis	1989
Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:1 Topics: Adult; Brain; Disability Evaluation; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1989
Pain in multiple sclerosis. Neurology, 1989, Volume: 39, Issue:7 Topics: Anti-Inflammatory Agents; Humans; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis; Pain	1989
Consensus and controversy in neurologic practice. The case of steroid treatment in multiple sclerosis. Archives of neurology, 1989, Volume: 46, Issue:3 Topics: Humans; Methylprednisolone; Multiple Sclerosis	1989
Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids. Italian journal of neurological sciences, 1989, Volume: 10, Issue:1 Topics: Adult; Aged; Blood-Brain Barrier; Humans; Immunoglobulin G; Injections, Spinal; Leukocyte Count; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Multiple Sclerosis	1989
Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone. Annals of neurology, 1985, Volume: 18, Issue:3 Topics: Adrenocorticotropic Hormone; Azathioprine; Blood-Brain Barrier; Drug Therapy, Combination; Humans; Immunoglobulin G; Methylprednisolone; Multiple Sclerosis; Prednisone	1985
Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo-Medrol. Zentralblatt fur Neurochirurgie, 1987, Volume: 48, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Arachnoid; Calcinosis; Female; Humans; Injections, Spinal; Methylprednisolone; Methylprednisolone Acetate; Multiple Sclerosis; Ossification, Heterotopic	1987
The need for a new strategy for the treatment of multiple sclerosis. Journal of neurology, 1988, Volume: 235, Issue:6 Topics: Blood-Brain Barrier; Central Nervous System; Cyclophosphamide; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis	1988
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisolone	1988
Multiple sclerosis, euthyroid restrictive Grave's ophthalmopathy, and myasthenia gravis. A case report. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1988, Volume: 226, Issue:2 Topics: Blepharoptosis; Diplopia; Graves Disease; Humans; Injections; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Multiple Sclerosis; Myasthenia Gravis; Oculomotor Muscles; Prednisone	1988
Methylprednisolone and multiple sclerosis. Archives of neurology, 1988, Volume: 45, Issue:6 Topics: Humans; Methylprednisolone; Multiple Sclerosis	1988
Steroid treatment in multiple sclerosis. Archives of neurology, 1988, Volume: 45, Issue:6 Topics: Humans; Methylprednisolone; Multiple Sclerosis	1988
Sequential computed tomography and 123I-HIPDM scans in multiple sclerosis with large plaque. A case report. European neurology, 1987, Volume: 27, Issue:2 Topics: Adult; Brain; Female; Humans; Iodobenzenes; Methylprednisolone; Multiple Sclerosis; Tomography, Emission-Computed; Tomography, X-Ray Computed	1987
Autoimmune optic neuritis: a potentially treatable form of visual loss. Annals of ophthalmology, 1986, Volume: 18, Issue:4 Topics: Adult; Autoimmune Diseases; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Multiple Sclerosis; Myasthenia Gravis; Optic Neuritis	1986
High-dose intravenous corticosteroids in the treatment of multiple sclerosis. Japanese journal of medicine, 1987, Volume: 26, Issue:2 Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Disability Evaluation; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisolone	1987
[A case of multiple sclerosis in a child which responded to methylprednisolone pulse therapy]. No to hattatsu = Brain and development, 1987, Volume: 19, Issue:4 Topics: Age Factors; Child; Drug Administration Schedule; Humans; Injections, Intravenous; Male; Methylprednisolone; Multiple Sclerosis; Remission Induction	1987
[Effect of pulse therapy on delayed contrast-enhancing CT scan lesion in a patient with multiple sclerosis]. Rinsho shinkeigaku = Clinical neurology, 1986, Volume: 26, Issue:1 Topics: Adult; Humans; Male; Methylprednisolone; Multiple Sclerosis; Pons; Tomography, X-Ray Computed	1986
[Diagnosis and therapy of optic neuritis]. Wiener medizinische Wochenschrift (1946), 1985, Jan-31, Volume: 135, Issue:1-2 Topics: Color Vision Defects; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Evoked Potentials, Visual; Humans; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Plasmapheresis; Prognosis; Reflex, Pupillary; Vision Disorders; Visual Acuity; Visual Fields	1985
Evoked potentials in multiple sclerosis before and after high-dose methylprednisolone infusion. European neurology, 1986, Volume: 25, Issue:1 Topics: Adult; Evoked Potentials; Evoked Potentials, Auditory; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Humans; Male; Median Nerve; Methylprednisolone; Multiple Sclerosis; Optic Neuritis; Prospective Studies; Tibial Nerve	1986
A case of multiple sclerosis with multi-ring-like and butterfly-like enhancement on computerized tomography. Brain & development, 1985, Volume: 7, Issue:1 Topics: Brain; Child; Humans; Male; Methylprednisolone; Multiple Sclerosis; Tomography, X-Ray Computed	1985
[Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years]. Revue neurologique, 1973, Volume: 128, Issue:1 Topics: Acetates; Adrenocorticotropic Hormone; Adult; Amenorrhea; Chlorambucil; Female; Follow-Up Studies; Humans; Hydroxocobalamin; Immune System Diseases; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Prednisone; Sex Factors; Time Factors	1973
[Multiple sclerosis. Clinico-statistical results of therapy based on intrathecal methylprednisolone acetate]. Minerva medica, 1974, Sep-19, Volume: 65, Issue:65 Topics: Adult; Evaluation Studies as Topic; Female; Humans; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1974
[Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results]. Ceskoslovenska neurologie a neurochirurgie, 1974, Volume: 37, Issue:5 Topics: Adult; Delayed-Action Preparations; Female; Humans; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Sheath	1974
[Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. II. Results in cerebrospinal fluid]. Ceskoslovenska neurologie a neurochirurgie, 1974, Volume: 37, Issue:5 Topics: Delayed-Action Preparations; Humans; Immunoglobulins; Injections, Spinal; Lymphocyte Activation; Methylprednisolone; Multiple Sclerosis; Myelin Sheath	1974
Complications from intrathecal steroid therapy in patients wsith multiple sclerosis. Acta neurologica Scandinavica, 1973, Volume: 49, Issue:2 Topics: Adult; Arachnoiditis; Cerebrospinal Fluid; Disability Evaluation; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Meningitis; Methods; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination	1973
Prevention of experimental allergic encephalomyelitis with cobra venom factor. The Journal of asthma research, 1971, Volume: 8, Issue:4 Topics: Animals; Cyclophosphamide; Encephalomyelitis, Autoimmune, Experimental; Humans; Hypersensitivity, Delayed; Methylprednisolone; Multiple Sclerosis; Rabbits; Rats; Snakes; Species Specificity; Venoms	1971
Polarizing solutions and intrathecal methylprednisolone acetate in therapy of multiple sclerosis: preliminary study. The Journal of the American Osteopathic Association, 1966, Volume: 65, Issue:7 Topics: Adolescent; Adult; Female; Humans; Injections, Spinal; Male; Methylprednisolone; Multiple Sclerosis; Solutions	1966
Polarizing solution and intrathecal methylprednisolone acetate in multiple sclerosis: follow-up study. The Journal of the American Osteopathic Association, 1967, Volume: 66, Issue:6 Topics: Adult; Female; Glucose; Humans; Injections, Spinal; Insulin; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Potassium Chloride; Solutions	1967
The management of the multiple sclerosis patient. Behavioral neuropsychiatry, 1969, Volume: 1, Issue:3 Topics: Activities of Daily Living; Adolescent; Adult; Ataxia; Child; Extremities; Eye Movements; Facial Paralysis; Family Characteristics; Female; Humans; Injections, Spinal; Male; Marriage; Methylprednisolone; Middle Aged; Multiple Sclerosis	1969
[Lumbar intrathecal injection of methylprednisolone acetate in the treatment of multiple sclerosis]. La Clinica terapeutica, 1969, Jan-31, Volume: 48, Issue:2 Topics: Adult; Female; Humans; Injections, Spinal; Lumbosacral Region; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1969
Peripheral uveitis in patients with multiple sclerosis. American journal of ophthalmology, 1970, Volume: 70, Issue:1 Topics: Adolescent; Adult; Female; Glucocorticoids; Humans; Intraocular Pressure; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Optic Nerve; Prednisone; Scotoma; Uveitis; Vision Disorders	1970
The need for functional rehabilitation in multiple sclerosis. Delaware medical journal, 1970, Volume: 42, Issue:5 Topics: Humans; Injections, Spinal; Methylprednisolone; Multiple Sclerosis; Physical Therapy Modalities; Rehabilitation, Vocational	1970
Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis. Transactions of the American Neurological Association, 1970, Volume: 95 Topics: Humans; Injections, Spinal; Methylprednisolone; Multiple Sclerosis	1970
The treatment of multiple sclerosis with intrathecally administered methylprednisolone acetate. The Journal of the Indiana State Medical Association, 1968, Volume: 61, Issue:9 Topics: Adult; Aged; Female; Humans; Injections, Spinal; Male; Methods; Methylprednisolone; Middle Aged; Multiple Sclerosis	1968
[Methylprednisolone acetate in intrathecal administration in multiple sclerosis]. Rassegna di neurologia vegetativa, 1965, Jun-30, Volume: 19, Issue:3 Topics: Adult; Female; Humans; Injections, Spinal; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis	1965